Document:

Exhibit 10.1

 

Myt
Netherlands Parent B.V.

2020 OMNIBUS INCENTIVE COMPENSATION PLAN

 

		1.	GENERAL

 

		1.1	Purpose

 

The purpose of the MYT Netherlands Parent
B.V. 2020 Omnibus Incentive Compensation Plan (as amended from time to time, the “Plan”) is to help the
Company (as hereinafter defined): (1) attract, retain and motivate key employees (including prospective employees) and consultants
and non-employee directors of the Company and its subsidiaries or affiliates; (2) align the interests of such persons with the
Company’s shareholders; and (3) promote ownership of the Company’s equity or pay incentive compensation, including
incentive compensation measured by reference to the value of the Company’s equity.

 

		1.2	Definitions of Certain Terms

 

For purposes of this Plan, the following
terms have the meanings set forth below:

 

		1.2.1	“Acquisition Awards” has the meaning set forth in Section 1.6.1.

 

		1.2.2	“ADSs” means American Depositary Shares, representing Ordinary Shares on deposit with a United States
banking institution or trust company selected by the Company and which are registered pursuant to a Form F-6.

 

		1.2.3	“Affiliate” means (i) any person or entity that directly or indirectly controls, is controlled by
or is under common control with the Company and/or (ii) to the extent provided by the Committee, any person or entity in which
the Company has a significant interest. The term “control” (including, with correlative meaning, the terms “controlled
by” and “under common control with”), as applied to any person or entity, means the possession, directly or indirectly,
of the power to direct or cause the direction of the management and policies of such person or entity, whether through the ownership
of voting or other securities, by contract or otherwise.

 

		1.2.4	“Applicable Exchange” means the New York Stock Exchange or such other securities exchange as may
at the applicable time be the principal market for the Shares.

 

		1.2.5	“Award” means an award made pursuant to the Plan.

 

		1.2.6	“Award Agreement” means the written document by which each Award is evidenced, and which may, but
need not be (as determined by the Committee) executed or acknowledged by a Grantee as a condition to receiving an Award or the
benefits under an Award, and which sets forth the terms and provisions applicable to Awards granted under the Plan to such Grantee.
Any reference herein to an agreement in writing will be deemed to include an electronic writing to the extent permitted by applicable
law.

 

		1.2.7	“Business Combination” has the meaning provided in the definition of Change in Control.

 

		1.2.8	“Cause” means (a) with respect to a Grantee employed pursuant to a written employment agreement which
agreement includes a definition of “Cause,” “Cause” as defined in that agreement or (b) with respect to
any other Grantee, except as otherwise set forth in an Award Agreement, the occurrence of any of the following: (i) such Grantee’s
conviction of, or plea of guilty or nolo contendere to, any felony or any crime involving fraud, dishonesty or moral turpitude
under the laws of the United States or any state thereof or under the laws of any other jurisdiction,
(ii) such Grantee’s attempted commission of, or participation in, a fraud or theft against the Company or any of its Subsidiaries
or Affiliates or any client thereof, (iii) such Grantee’s engagement in gross misconduct that causes financial or reputation
harm to the Company or any of its Subsidiaries or Affiliates, (iv) such Grantee’s repeated failure to substantially perform
his or her duties and responsibilities to the Company or any of its Subsidiaries or Affiliates (other than failure resulting from
such Grantee’s Disability), (v) such Grantee’s material violation of any contract or agreement between the Grantee
and the Company or any of its Subsidiaries or Affiliates, or any written policy or provision of the code of business conduct and
ethics or any other established code of conduct of the Company or any of its Subsidiaries or Affiliates, in each case, to which
such Grantee is subject or (vi) such Grantee’s habitual abuse of narcotics.

 

     

     

    

 

		1.2.9	“Certificate” means a share certificate, an extract of the relevant pages of the register of shareholders
of the Company or other appropriate document or evidence of ownership representing Shares.

 

		1.2.10	“Change in Control” means, unless otherwise set forth in an Award Agreement, the occurrence of any
of the following events:

 

(a)              
during any period of not more than 36 months, individuals who constitute the Supervisory Board as of the beginning of the
period (the “Incumbent Supervisory Board Members”) cease for any reason to constitute at least a majority
of the Supervisory Board, provided, that any person becoming a member of the Supervisory Board subsequent to the
beginning of such period, whose nomination for appointment was approved by a vote of at least three-quarters of the Incumbent
Supervisory Board Members then serving on the Supervisory Board (which approval may be evidenced by the adoption of a specific
resolution on such nomination or by adoption of a resolution approving the proxy statement of the Company in which such person
is named as a nominee for the Supervisory Board) will be an Incumbent Supervisory Board Member; provided, that
no individual initially appointed to the Supervisory Board who was not nominated for appointment by a vote of at least three-quarters
of the Incumbent Supervisory Board Members will be deemed to be an Incumbent Supervisory Board Member;

 

(b)             
any “person” (as such term is defined in Section 3(a)(9) of the Exchange Act and as used in Sections 13(d)(3)
and 14(d)(2) of the Exchange Act), is or becomes a “beneficial owner” (as defined in Rule 13d-3 under the Exchange
Act), directly or indirectly, of securities of the Company representing 50% or more of the combined voting power of the Company’s
then-outstanding securities eligible to vote for the election of the Supervisory Board (“Company Voting Securities”);
provided, that the event described in this paragraph (a) will not be deemed to be a Change in Control by virtue of the ownership,
or acquisition, of Company Voting Securities: (A) by the Company or any of its Affiliates, (B) by any employee benefit plan (or
related trust) sponsored or maintained by the Company or any of its Affiliates, (C) by any Affiliate of any Sponsor; (D) by any
Dutch foundation (stichting) pursuant to a call option authorized by the shareholders of the Company or pursuant to the conversion
of any preference shares issued upon exercise thereof; (E) by any underwriter temporarily holding securities pursuant to an offering
of such securities or (F) pursuant to a Non-Qualifying Transaction (as defined in paragraph (b) of this definition);

 

(c)               the
consummation of a merger, consolidation, statutory share exchange or similar form of corporate transaction involving the
Company that requires the approval of the general meeting of the Company, whether for such transaction or the issuance of
securities in the transaction (a “Business Combination”), unless immediately following such
Business Combination: (A) more than 50% of the total voting power of the entity resulting from such Business Combination (the
 “Surviving Entity”) is represented by Company Voting Securities that were outstanding immediately
prior to such Business Combination (or, if applicable, is represented by shares into which such Company Voting Securities
were converted pursuant to such Business Combination), and such voting power among the holders thereof is in substantially
the same proportion as the voting power of such Company Voting Securities among the holders thereof immediately prior to the
Business Combination, (B) no person (other than any employee benefit plan (or related trust) sponsored or maintained by the
Surviving Entity or the parent), is or becomes the beneficial owner, directly or indirectly, of 50% or more of the total
voting power of the outstanding voting securities eligible to elect directors of the parent (or, if there is no parent, the
Surviving Entity) and (C) at least a majority of the members of the board of directors of the parent (or, if there is no
parent, the Surviving Entity) following the consummation of the Business Combination were Incumbent Supervisory Board Members
at the time of the Supervisory Board’s approval of the execution of the initial agreement providing for such Business
Combination (any Business Combination which satisfies all of the criteria specified in (A), (B) and (C) of this paragraph (c)
will be deemed to be a “Non-Qualifying Transaction”); or

 

    2

     

    

 

(d)             
the consummation of a sale of all or substantially all of the Company’s assets (other than to any Sponsor or any direct
or indirect Subsidiary or Affiliate of any Sponsor or any Affiliate of the Company); or

 

(e)              
the general meeting of the Company resolves to liquidate the Company;

 

provided, that the consummation of
an IPO shall not constitute a Change in Control.

 

Notwithstanding the foregoing, a Change
in Control will not be deemed to occur solely because any person acquires beneficial ownership of more than 50% of the Company
Voting Securities as a result of the acquisition of Company Voting Securities by the Company which reduces the number of Company
Voting Securities outstanding; provided, that if after such acquisition by the Company such person (other than any Sponsor
or any direct or indirect Subsidiary or Affiliate of any Sponsor) becomes the beneficial owner of additional Company Voting Securities
that increases the percentage of outstanding Company Voting Securities beneficially owned by such person, a Change in Control will
then occur.

 

		1.2.11	“Committee” means the Nominating, Governance and Compensation Committee of the Supervisory Board
or such other committee of the Supervisory Board as the Supervisory Board may from time to time designate, which committee shall
be composed of not less than two members of the Supervisory Board, or, if no such committee exists, the Supervisory Board.

 

		1.2.12	“Company” means MYT Netherlands Parent B.V., a private company with limited liability (besloten
vennotschap met beperkte aansprakelijkheid) incorporated and existing under the laws of the Netherlands, and any successor
entity thereto.

 

		1.2.13	“Company Voting Securities” has the meaning provided in the definition of Change in Control.

 

		1.2.14	“Consent” has the meaning set forth in Section 3.3.2.

 

		1.2.15	“Consultant” means any individual (other than a non-employee Director or Supervisory Board Member),
who is a natural person that provides bona fide consulting or advisory services to the Company or any of its Subsidiaries or Affiliates,
and such services are not in connection with the offer or sale of securities in a capital-raising transaction, and do not directly
or indirectly promote or maintain a market for the registrant’s securities.

 

		1.2.16	“Covered Person” has the meaning set forth in Section 1.3.5.

 

		1.2.17	“Director” means a member of the Management Board.

 

		1.2.18	“Disability” means (a) with respect to a Grantee employed pursuant to a written employment
                                                              agreement which agreement includes a definition of “Disability,” “Disability” as defined in that
                                                              agreement or (b) with respect to any other Grantee, the Grantee is unable to perform the essential functions of
                                                              Grantee’s job, with a reasonable accommodation, due to illness
or injury for such duration as entitles Grantee to long-term disability payments under the long-term disability plan of the Company
or any of its Subsidiaries or Affiliates in which Grantee participates, or if there is no such plan applicable to the Grantee or
the Committee determines otherwise in an Award Agreement, “Disability” as determined by the Committee.

 

    3

     

    

 

		1.2.19	“Effective Date” has the meaning set forth in Section 3.24.

 

		1.2.20	“Employee” means a regular, active employee of the Company or any of its Subsidiaries or Affiliates,
but not including a non-employee Director or Supervisory Board Member.

 

		1.2.21	“Employment” means a Grantee’s performance of services for the Company or any of its Subsidiaries
or Affiliates, as determined by the Committee. The terms “employ” and “employed” will have their correlative
meanings. The Committee in its sole discretion may determine (a) whether and when a Grantee’s leave of absence results in
a termination of Employment, (b) whether and when a change in a Grantee’s association with the Company or any of its Subsidiaries
or Affiliates results in a termination of Employment and (c) the impact, if any, of any such leave of absence or change in association
on outstanding Awards. Unless expressly provided otherwise, any references in the Plan or any Award Agreement to a Grantee’s
Employment being terminated will include both voluntary and involuntary terminations.

 

		1.2.22	“Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time, or any successor
thereto, and the applicable rules and regulations thereunder.

 

		1.2.23	“Fair Market Value” means, with respect to a Share, (i) if the Shares are listed on one or more established
stock exchanges or traded on one or more automated quotation systems, the closing price of a Share as reported on the Applicable
Exchange on the date of measurement, or if Shares were not traded on the Applicable Exchange on such measurement date, then on
the next preceding date on which Shares were traded, or (ii) if the Shares are not listed on an established stock exchange or traded
on an automated quotation system, as determined in accordance with a valuation methodology approved by the Committee, unless determined
as otherwise specified herein. For purposes of the grant of any Award, the applicable date will be the trading day on which the
Award is granted or, if the date the Award is granted is not a trading day, the trading day immediately prior to the date the Award
is granted. For purposes of the exercise of any Award, the applicable date is the date a notice of exercise is received by the
Company or, if such date is not a trading day, the trading day immediately following the date a notice of exercise is received
by the Company.

 

		1.2.24	“Grantee” means an Employee, Consultant, Director or Supervisory Board Member who receives an Award.

 

		1.2.25	“Incumbent Board Members” has the meaning provided in the definition of Change in Control.

 

		1.2.26	“Initial Public Offering” or “IPO” means an initial public offering of
the Ordinary Shares or American Depositary Shares, Global Depositary Shares or similar instruments representing Ordinary Shares
(or the right to receive Ordinary Shares) pursuant to an effective registration statement (other than a registration statement
on Form F-4 or Form S-8 or any similar form) filed under the Securities Act.

 

		1.2.27	“Management Board” means the management board of the Company.

 

		1.2.28	“Non-Qualifying Transaction” has the meaning provided in the definition of Change in Control.

 

    4

     

    

 

		1.2.29	“Ordinary Share” means an ordinary share in the share capital of the Company.

 

		1.2.30	“Other Share-Based or Cash-Based Awards” has the meaning set forth in Section 2.6.1.

 

		1.2.31	“Plan” has the meaning set forth in Section 1.1.

 

		1.2.32	“Plan Action” has the meaning set forth in Section 3.3.1.

 

		1.2.33	“Securities Act” means the Securities Act of 1933, as amended from time to time, or any successor
thereto, and the applicable rules and regulations thereunder.

 

		1.2.34	“Share Limit” has the meaning set forth in Section 1.6.1.

 

		1.2.35	“Share” means an Ordinary Share, unless the Company shall have completed the issuance and listing
of ADSs on the New York Stock Exchange, the Nasdaq Stock Market or an equivalent public listing on a non-U.S. securities exchange,
in which case, “Share” will mean the number of ADSs equal to one Ordinary Share. If the ratio of ADSs to Ordinary Shares
is not 1:1, then (a) all amounts determined under Section 4 and (b) all Awards designated as Awards over Ordinary Shares
will automatically be adjusted to reflect the ratio of the ADSs to Ordinary Shares, as reasonably determined by the Committee.

 

		1.2.36	“Sponsor” means either of Ares Management, L.P. or CPP Investment Board (USRE) Inc.

 

		1.2.37	“Subsidiary” means any corporation, partnership, limited liability company or other legal entity
in which the Company, directly or indirectly, owns shares or other equity interests possessing 50% or more of the total combined
voting power of all classes of the then-outstanding shares or other equity interests.

 

		1.2.38	“Supervisory Board” means the supervisory board of the Company.

 

		1.2.39	“Supervisory Board Member” means a member of the Supervisory Board.

 

		1.2.40	“Surviving Entity” has the meaning provided in the definition of Change in Control.

 

		1.2.41	“Tax-Related Items” means any federal, national, provincial, state, and/or local taxes (including,
without limitation, income tax, social insurance contributions (or similar contributions), payroll tax, fringe benefits tax, payment
on account, employment tax, stamp tax and any other tax or tax-related item) related to participation in the Plan and legally applicable
to a Grantee, including any employer liability for which the Grantee is liable pursuant to applicable laws or the applicable Award
Agreement.

 

		1.3	Administration

 

		1.3.1	The Committee (as constituted from time to time, and including any successor thereto) will administer the Plan. The Committee
shall have plenary authority to grant Awards pursuant to the terms of this Plan to Directors and shall have the authority to approve
any grants of Awards proposed by the Management Board to be made pursuant to the terms of this Plan to Employees and Consultants
who are not Directors. In particular, the Committee will have the authority in its sole discretion to:

 

(a)              
exercise all of the powers granted to it under the Plan;

 

(b)             
construe, interpret and implement the Plan and all Award Agreements;

 

    5

     

    

 

(c)               prescribe,
amend and rescind rules and regulations relating to the Plan, including rules governing the Committee’s own operations
and, without limiting the foregoing, to make exceptions to any such rules or regulations if the Committee, in good faith,
determines appropriate in light of extraordinary circumstances and for the benefit of the Company and so as to avoid
unanticipated consequences or address unanticipated events (including any temporary closure of an Applicable Exchange,
disruption of communications or natural catastrophe) and appoint such agents as the Committee shall deem appropriate for the
proper administration of the Plan;

 

(d)             
make all determinations necessary or advisable in administering the Plan;

 

(e)              
correct any defect, supply any omission and reconcile any inconsistency in the Plan;

 

(f)              
amend the Plan to reflect changes in applicable law;

 

(g)             
grant, or recommend to the Supervisory Board for approval to grant, Awards and determine (in the case of Directors) or approve
the determination proposed by the Management Board (in the case of Employees and Consultants who are not Directors) who will receive
Awards, when such Awards will be granted and the terms of such Awards, including setting forth provisions with regard to the effect
of a termination of Employment on such Awards and conditioning the vesting of, or the lapsing of any applicable vesting restrictions
or other vesting conditions on, Awards upon the attainment of performance goals and/or upon continued service;

 

(h)             
amend any outstanding Award Agreement in any respect including, without limitation, to

 

(1)             
accelerate the time or times at which the Award becomes vested, unrestricted or may be exercised (and, in connection with
such acceleration, the Committee may provide that any Shares acquired pursuant to such Award will be restricted shares, which are
subject to vesting, transfer, forfeiture or repayment provisions similar to those in the Grantee’s underlying Award),

 

(2)             
accelerate the time or times at which Shares are delivered under the Award (and, without limitation on the Committee’s
rights, in connection with such acceleration, the Committee may provide that any Shares delivered pursuant to such Award will be
restricted shares, which are subject to vesting, transfer, forfeiture or repayment provisions similar to those in the Grantee’s
underlying Award),

 

(3)             
waive or amend any goals, restrictions, vesting provisions or conditions set forth in such Award Agreement, or impose new
goals, restrictions, vesting provisions and conditions, subject to Section 3.1 or

 

(4)             
reflect a change in the Grantee’s circumstances (e.g., a change to part-time employment status or a change in position,
duties or responsibilities); and

 

(i)               
determine at any time whether, to what extent and under what circumstances and method or methods:

 

(1)             
Awards may be (A) settled in cash, Shares, other securities, other Awards or other property (in which event, the Committee
may specify what other effects such settlement will have on the Grantee’s Award, including the effect on any repayment provisions
under the Plan or Award Agreement), (B) exercised or (C) canceled, forfeited or suspended,

 

(2)             
Shares, other securities, other Awards or other property and other amounts payable with respect to an Award may be deferred
either automatically or at the election of the Grantee thereof or of the Committee,

 

(3)             
 the exercise price for any share option may be reset, subject to Section 2.3.5.

 

    6

     

    

 

		1.3.2	Actions of the Committee may be taken by the vote of a majority of its members present at a meeting (which may be held telephonically).
Any action may be taken by a written instrument signed by a majority of the Committee members, and action so taken will be as fully
effective as if it had been taken by a vote at a meeting. The determination of the Committee on all matters relating to the Plan
or any Award Agreement will be final, binding and conclusive on all persons (including any Grantee). Subject to applicable law
or the listing standards of the Applicable Exchange, the Committee may allocate among its members and delegate to any person who
is not a member of the Committee, or to any administrative group within the Company, any of its powers, responsibilities or duties.
Except as specifically provided to the contrary, references to the Committee include any administrative group, individual or individuals
to whom the Committee has delegated its duties and powers.

 

		1.3.3	Notwithstanding anything to the contrary contained herein, the Supervisory Board may, in its sole discretion, at any time and
from time to time, grant Awards or administer the Plan, subject to applicable law or the listing standards of the Applicable Exchange.
In any such case, the full Supervisory Board will have all of the authority and responsibility granted to any committee of the
Supervisory Board that is designated as the Committee herein and, to the extent that any permitted action taken by the Supervisory
Board conflicts with action taken by such Committee, the Supervisory Board action shall control.

 

		1.3.4	Upon Awards being granted in accordance with the provisions of this Plan, the Management Board shall procure that it takes
all relevant corporate action to give effect to such grant.

 

		1.3.5	No member of the Committee, person to whom the Committee delegates its powers, responsibilities or duties in writing, including
by resolution or member of the Supervisory Board or Management Board (each such person, a “Covered Person”),
will have any liability to any person (including any Grantee) for any action taken or omitted to be taken or any determination
made with respect to the Plan or any Award, except as expressly provided by statute. Each Covered Person will be indemnified and
held harmless by the Company against and from:

 

(a)              
any loss, cost, liability or expense (including reasonable attorneys’ fees) that may be imposed upon or incurred by
such Covered Person in connection with or resulting from any action, suit or proceeding to which such Covered Person may be a party
or in which such Covered Person may be involved by reason of any action taken or omitted to be taken under the Plan or any Award
Agreement, in each case, in good faith and

 

(b)             
any and all amounts paid by such Covered Person, with the Company’s approval, in settlement thereof, or paid by such
Covered Person in satisfaction of any judgment in any such action, suit or proceeding against such Covered Person. The Company
will have the right, at its own expense, to assume and defend any such action, suit or proceeding and, once the Company gives notice
of its intent to assume the defense, the Company will have sole control over such defense with counsel of the Company’s choice.

 

The foregoing right of indemnification will
not be available to a Covered Person to the extent that a court of competent jurisdiction in a final judgment or other final adjudication,
in either case, not subject to further appeal, determines that the acts or omissions of such Covered Person giving rise to the
indemnification claim resulted from such Covered Person’s bad faith, fraud or willful misconduct. The foregoing right of
indemnification will not be exclusive of any other rights of indemnification to which Covered Persons may be entitled under any
directors and officers liability insurance, in each case, as amended from time to time, pursuant to any individual indemnification
agreements between such Covered Person and the Company, as a matter of law, or otherwise, or any other power that the Company may
have to indemnify such persons or hold them harmless.

 

    7

     

    

 

		1.4	Persons Eligible for Awards

 

Awards under the Plan may be made to Employees,
Consultants, Directors and Supervisory Board Members.

 

		1.5	Types of Awards Under Plan

 

Awards may be made under the Plan in the
form of cash-based or share-based Awards. Share-based Awards may be in the form of any of the following, in each case in respect
of Shares:

 

(a)              
share options, meaning an Award providing the Grantee with a right to acquire a designated number of Shares at a certain
exercise price pursuant to Section 2.3,

 

(b)             
restricted shares,

 

(c)              
restricted share units, and

 

(d)             
performance-based or other equity-based or equity-related Awards, including phantom shares (as further described in Section 2.6),
that the Committee determines to be consistent with the purposes of the Plan and the interests of the Company.

 

		1.6	Shares Available for Awards

 

		1.6.1	Shares Subject to the Plan. Subject to the other provisions of this Section 1.6, the total number of Shares
that may be granted under the Plan will be equal to 13.75% of the outstanding share capital of the Company on the Effective Date
(the “Share Limit”); provided, that in the event of an Initial Public Offering, the Share Limit
shall be adjusted so that the Share Limit shall be equal to 13.75% of the outstanding share capital of the Company as of the closing
date of the exercise of any overallotment option by any of the managing underwriters in connection with the Initial Public Offering
or, if the managing underwriters deliver notice to the Company that they are waiving the overallotment option, on the date of such
notice of waiver or, if the managing underwriters neither exercise the overallotment option nor deliver notice of waiver, the date
of expiration of such overallotment option.

 

		1.6.2	Shares subject to awards that are assumed, converted or substituted under the Plan as a result of the Company’s acquisition
of another company (including by way of merger, combination or similar transaction) (“Acquisition Awards”)
will not count against the number of shares that may be granted under the Plan. Available shares under a shareholder approved plan
of an acquired company (as appropriately adjusted to reflect the transaction) may be used for Awards under the Plan and do not
reduce the maximum number of shares available for grant under the Plan, subject to Applicable Exchange requirements. The Shares
issued pursuant to Awards granted under this Plan may be Shares that are unissued or Shares that were reacquired by the Company,
including treasury Shares or Shares purchased in the open market, or ADSs.

 

		1.6.3	Replacement of Shares. Shares subject to an Award that is forfeited (including any restricted shares repurchased
by the Company at the same price paid by the Grantee so that such Shares are returned to the Company), expires or is settled for
cash (in whole or in part), to the extent of such forfeiture, expiration or cash settlement will be available for future grants
of Awards under the Plan and will be added back in the same number of Shares as were deducted in respect of the grant of such Award.
Shares tendered by a Grantee or withheld by the Company in payment of the exercise price of a share option or to satisfy any Tax-Related
Items required to be withheld respect to an Award will be available for future grants of Awards.

 

    8

     

    

 

		1.6.4	Adjustments. The Committee will:

 

(a)              
adjust the number of Shares authorized pursuant to Section 1.6.1,

 

(b)             
adjust the terms of any outstanding Awards (including, without limitation, the number of Shares covered by each outstanding
Award, the type of property or securities to which the Award relates and the exercise or strike price of any Award), in a proportionate
manner as the Committee determines in good-faith to be appropriate and equitable (including, without limitation, by payment of
cash) to prevent the enlargement or dilution of rights, as a result of any increase or decrease in the number of issued Shares
(or issuance of equity securities other than Shares) resulting from a recapitalization, share split, reverse share split, share
dividend, spinoff, split up, combination, reclassification or exchange of Shares, merger, consolidation, rights offering, separation,
reorganization or liquidation or any other change in the corporate structure or Shares, including any extraordinary dividend or
extraordinary distribution.

 

Any adjustment under this Section 1.6.3
need not be the same for all Grantees.

 

		1.7	Awards to Supervisory Board Members

 

The general meeting of the Company has the
authority to grant Awards pursuant to the terms of this Plan to Supervisory Board Members. The Supervisory Board Members may submit
a proposal for their Awards to the general meeting of the Company. Notwithstanding any provisions contained in the Plan to the
contrary, only the general meeting of the Company may amend any outstanding Award Agreement with any of the Supervisory Board Members
in any respect. Any provision of this Plan shall be interpreted in accordance with this Section 1.7.

 

		1.8	Limits on Compensation to Directors and Supervisory Board Members

 

The amount, terms and other conditions of
Awards granted to any Director or Supervisory Board Member shall be subject to the limitations and requirements set forth in the
Company’s remuneration policy, as in effect from time to time, applicable to the Directors and Supervisory Board Members.

 

		1.9	Share Transfer and Issuance Formalities

 

Under Dutch law, any transfer of issuance
of Shares in order to be valid shall require the execution of a deed to that effect by a Dutch notary.

 

		1.10	Issuance of Shares Prior to an IPO

 

Notwithstanding any provisions contained
in the Plan or any Award Agreement to the contrary, if any Shares would otherwise be issued to any participants pursuant to an
Award granted under the Plan at any time prior to the occurrence of an IPO, the Company shall have the option at its sole election
of issuing such Shares to a Dutch foundation, in lieu of issuing such Shares directly to the participants, and, in turn, the Dutch
foundation shall issue depositary receipts for such Shares to such participants, each of which represents the right to receive
profits and other distributions in respect of such Shares, but shall not confer any voting rights on such participants with respect
to such Shares.  The voting rights on any such Shares held by the Dutch foundation shall be held and controlled by the Dutch
foundation.  If an IPO occurs at any time following any issuance of Shares to the Dutch foundation, then upon or promptly
following the IPO, the Dutch foundation shall be terminated and the Shares (or ADSs or other Share equivalents) shall be distributed
to the participants in respect of whom the Shares are then-held by the Dutch Foundation.

 

    9

     

    

 

		2.	AWARDS UNDER THE PLAN

 

		2.1	Agreements Evidencing Awards

 

Each Award granted under the Plan will be
evidenced by an Award Agreement that will contain such provisions and conditions as the Committee deems appropriate and shall be
delivered to the Grantee receiving such Award upon, or as promptly as is reasonably practicable following, the grant of the Award.
The effectiveness of an Award shall not be subject to the Award Agreement being signed by the Company and/or the Grantee unless
specifically so provided in the Award Agreement. Unless otherwise provided herein, the Committee may grant Awards in tandem with
or in substitution for or satisfaction of any other Award or Awards granted under the Plan or any award granted under any other
plan of the Company. By accepting an Award pursuant to the Plan, a Grantee thereby agrees that the Award will be subject to all
of the terms and provisions of the Plan and the applicable Award Agreement.

 

		2.2	No Rights as a Shareholder

 

No Grantee (or other person having rights
pursuant to an Award) will have any of the rights of a shareholder of the Company with respect to Shares subject to an Award until
the delivery of such Shares. Except as otherwise provided in Section 1.6.3, no adjustments will be made for dividends, distributions
or other rights (whether ordinary or extraordinary, and whether in cash, Shares, other securities or other property) for which
the record date is before the date the Shares are delivered, or in the event the Company elects to use another system, such as
book entries by the transfer agent, before the date in which such system evidences the Grantee’s ownership of such Shares.

 

		2.3	Options

 

		2.3.1	Grant. Share options may be granted to eligible recipients in such number and at such times during the term of
the Plan as the Committee may determine.

 

		2.3.2	Exercise Price. The exercise price per Share with respect to each share option will be determined by the Committee
but, except as otherwise permitted by Section 1.6.3 or for any Acquisition Awards or as otherwise approved by the Committee
and set forth in an Award Agreement, may never be less than the Fair Market Value of a Share on the date of grant. Unless otherwise
noted in the Award Agreement, the Fair Market Value of the Shares will be the Fair Market Value on the date of grant of the Award
of share options.

 

		2.3.3	Term of Share Option. In no event will any share option be exercisable after the expiration of 10 years from
the date on which the share option is granted.

 

		2.3.4	Vesting and Exercise of Share Option and Payment for Shares. A share option may vest and be exercised at such
time or times and subject to such terms and conditions as will be determined by the Committee at the time the share option is granted
and set forth in the Award Agreement. Subject to any limitations in the applicable Award Agreement, any Shares not acquired pursuant
to the exercise of a share option on the applicable vesting date may be acquired thereafter at any time before the final expiration
of the share option.

 

    10

     

    

 

To exercise a share option, the Grantee
must give written notice to the Company specifying the number of Shares to be acquired and accompanied by payment of the full purchase
price therefor in cash or by certified or official bank check or in another form as determined by the Committee, which may include:

 

(a)              
personal check,

 

(b)             
 Shares, based on the Fair Market Value as of the exercise date,

 

(c)              
any other form of consideration approved by the Company and permitted by applicable law and

 

(d)             
any combination of the foregoing.

 

The Committee may also make arrangements
for the cashless exercise of a share option. Any person exercising a share option will make such representations and agreements
and furnish such information as the Committee may, in its sole discretion, deem necessary or desirable to effect or assure compliance
by the Company on terms acceptable to the Company with the provisions of the Securities Act, the Exchange Act and any other applicable
legal requirements. The Committee may, in its sole discretion, also take whatever additional actions it deems appropriate to effect
such compliance including, without limitation, issuing stop-transfer notices to agents and registrars. If a Grantee so requests,
Shares acquired pursuant to the exercise of a share option may be issued in the name of the Grantee and another jointly with the
right of survivorship.

 

Notwithstanding anything to the contrary
contained herein, upon the exercise of a share option resulting in an issuance of Shares, the Grantee shall immediately pay in
cash the nominal value of an Ordinary Share in connection with such issuance, unless the Committee has decided that such par value
shall be charged against the Company’s reserves (subject to applicable law).

 

		2.3.5	Repricing. Except as otherwise permitted by Section 1.6.3, the Committee shall not, without the approval
by the general meeting of the Company (a) reduce the exercise price of share options issued and outstanding under the Plan, (b)
amend or cancel a share option when the exercise price exceeds the Fair Market Value of one Share in exchange for the grant of
a substitute Award or repurchase for cash or other consideration, in each case with the effect of reducing the exercise price and
except in accordance with Section 3.6, or (c) take any other action with respect to a share option that would be treated
as a repricing under the rules and regulations of the Applicable Exchange.

 

		2.4	Restricted Shares

 

		2.4.1	Grants. The Committee may grant or offer for sale restricted shares in such amounts and subject to such terms
and conditions as the Committee may determine. Upon the delivery of such shares, the Grantee will have the rights of a shareholder
with respect to the restricted shares, subject to any other restrictions and conditions as the Committee may include in the applicable
Award Agreement. Each Grantee of an Award of restricted shares will be issued a Certificate in respect of such shares, unless the
Committee elects to use another system, such as book entries by the transfer agent, as evidencing ownership of such shares.

 

Upon the issuance of restricted shares,
the Grantee shall immediately pay in cash the par value of an Ordinary Share in connection with such issuance, unless the Committee
has decided that such par value shall be charged against the Company’s reserves (subject to applicable law).

 

		2.4.2	Right to Vote and Receive Dividends on Restricted Shares. Each Grantee of an Award of restricted shares
will, during the period of restriction, be the beneficial and record owner of such restricted shares and will have full voting
rights with respect thereto. Unless the Committee determines otherwise in an Award Agreement, during the period of restriction,
all ordinary cash dividends or other ordinary distributions paid upon any restricted share will be retained by the Company and
will be paid to the relevant Grantee (without interest) when the Award of restricted shares vests and will revert back to the Company
if for any reason the restricted share upon which such dividends or other distributions were paid reverts back to the Company (any
extraordinary dividends or other extraordinary distributions will be treated in accordance with Section 1.6.3).

 

    11

     

    

 

		2.5	Restricted Share Units

 

The Committee may grant Awards of restricted
share units in such amounts and subject to such terms and conditions as the Committee may determine. A Grantee of a restricted
share unit will have only the rights of a general unsecured creditor of the Company, until delivery of Shares, cash or other securities
or property is made as specified in the applicable Award Agreement. On the delivery date specified in the Award Agreement, the
Grantee of each restricted share unit not previously forfeited or terminated will receive one Share, cash or other securities or
property equal in value to a Share or a combination thereof, as specified by the Committee.

 

Upon the vesting of a restricted share unit
resulting in an issuance of Shares, the Grantee shall immediately pay in cash the par value of an Ordinary Share in connection
with such issuance, unless the Committee has decided that such par value shall be charged against the Company’s reserves
(subject to applicable law).

 

		2.6	Performance-Based and Other Share-Based or Cash-Based Awards

 

		2.6.1	Grant. The Committee may grant other types of equity-based, equity-related or cash-based Awards (including the
grant or offer for sale of unrestricted Shares, performance share awards, performance units settled in cash and phantom shares)
(“Other Share-Based or Cash-Based Awards”) in such amounts and subject to such terms and conditions as
the Committee may determine. The terms and conditions set forth by the Committee in the applicable Award Agreement may relate to
the achievement of performance goals, as determined by the Committee at the time of grant. Such Awards may entail the transfer
of actual Shares to Award recipients and may include Awards designed to comply with or take advantage of the applicable local laws
of jurisdictions other than the Netherlands.

 

		2.6.2	Performance Criteria. The performance goals may be based on one or more of the following business criteria (either
separately or in combination) with regard to the Company (or a Subsidiary, division, other operational unit or administrative department
of the Company), or such other performance goal as the Committee determines appropriate: measures of efficiency (including operating
efficiency, productivity ratios or other similar measures); measures of achievement of expense targets, costs reductions, working
capital, cash levels or general expense ratios; asset growth; earnings per share or net earnings; enterprise value or value creation
targets; combined net worth; debt to equity ratio; revenues, sales, net revenues or net sales measures; gross profit or operating
profit measures (including before or after taxes or other similar measures); investment performance; income or operating income
measures (with or without investment income or income taxes, before or after risk-adjustment, or other similar measures); cash
flow; margin; net income, before or after taxes; earnings before interest, taxes, depreciation and/or amortization; return measures
(including return on capital, invested capital, total capital, tangible capital, expenses, tangible expenses, equity, revenue,
investment, assets, or net assets or total shareholder return or similar measures); market share measures; measures of balance
sheet achievements (including debt reductions, leverage ratios or other similar measures); increase in the Fair Market Value of
Shares; changes (or the absence of changes) in the per share or aggregate Fair Market Value of Shares (including total shareholder
returns); and number of securities sold and funds from operations. Any of the foregoing performance goals may be measured in absolute
terms or relative to historic performance or the performance of other companies or an index.

 

		3.	MISCELLANEOUS

 

		3.1	Amendment of the Plan

 

		3.1.1	Unless otherwise provided in the Plan or in an Award Agreement, the Supervisory Board may at any time and from time to
                                                             time suspend, discontinue, revise or amend the Plan in any respect whatsoever but, subject to Sections 1.6.3, 1.7, 1.8,
                                                             and 3.6, no such amendment may materially adversely impair the rights of the Grantee of any Award without the
                                                             Grantee’s consent. Subject to Sections 1.6.3 and 3.6, an Award Agreement may not be amended to materially
                                                             adversely impair the rights of a Grantee without the Grantee’s consent.

 

    12

     

    

 

		3.1.2	Unless otherwise determined by the Supervisory Board, approval of the general meeting of the Company of any suspension, discontinuance,
revision or amendment will be obtained only to the extent necessary to comply with any applicable laws, regulations or rules of
an Applicable Exchange or self-regulatory agency.

 

		3.2	Tax Withholding

 

Grantees will be solely responsible for
any Tax-Related Items (including any penalties and any interest that accrues thereon) that they incur in connection with the receipt,
vesting, exercise or settlement of any Award. As a condition to the delivery of any Shares, cash or other securities or property
pursuant to any Award or the lifting or lapse of restrictions on any Award, or in connection with any other event that gives rise
to any withholding obligation for Tax-Related Items on the part of the Company relating to an Award:

 

(a)              
the Company may deduct or withhold (or cause to be deducted or withheld) from any payment or distribution to a Grantee from
the Company or any of its Subsidiaries or Affiliates whether or not pursuant to the Plan (including Shares otherwise deliverable),

 

(b)             
the Committee will be entitled to require that the Grantee remit cash to the Company (through payroll deduction or otherwise)
or

 

(c)              
the Company may enter into any other suitable arrangements to withhold, in each case, in the Committee’s discretion,
amounts of such Tax-Related Items required by law to be withheld, based upon the maximum required tax withholding rate for the
Grantee (or such other rate that will not cause an adverse accounting consequence or cost), including the delivery of Shares (which
are not subject to any pledge or other security interest) that have been both held by the Grantee and vested for at least six months
(or such other period as established by the Committee to avoid adverse accounting consequence or cost) having an aggregate Fair
Market Value approximately equal to the amount to be withheld, the sale of Shares issued pursuant to an Award and having the Company
withhold from the proceeds of the sale of such Shares, or any other method of withholding determined by the Committee that is permissible
under applicable law.

 

		3.3	Required Consents

 

		3.3.1	If the Committee at any time determines that any Consent (as hereinafter defined) is necessary or desirable as a condition
of, or in connection with, the granting of any Award, the delivery of Shares or the delivery of any cash, securities or other property
under the Plan, or the taking of any other action thereunder (each such action a “Plan Action”), then
such Plan Action will not be taken, in whole or in part, unless and until such Consent will have been effected or obtained to the
full satisfaction of the Committee.

 

		3.3.2	The term “Consent” as used in this Section 3.3 with respect to any Plan Action includes:

 

(a)              
any and all listings, registrations or qualifications in respect thereof upon any Applicable Exchange or under any federal,
state, or local law, or law, rule or regulation of a jurisdiction outside the Netherlands,

 

    13

     

    

 

(b)             
 any and all written agreements and representations by the Grantee with respect to the disposition of Shares, or with respect
to any other matter, which the Committee may deem necessary or desirable to comply with the terms of any such listing, registration
or qualification or to obtain an exemption from the requirement that any such listing, qualification or registration be made,

 

(c)              
any and all other consents, clearances and approvals in respect of a Plan Action by any governmental or other regulatory
body or any stock exchange or self-regulatory agency,

 

(d)             
any and all consents by the Grantee to:

 

(1)          
the Company’s supplying to any third party recordkeeper of the Plan such personal information as the Committee deems
advisable to administer the Plan,

 

(2)          
the Company’s deducting amounts from the Grantee’s wages, or another arrangement satisfactory to the Committee,
to reimburse the Company for advances made on the Grantee’s behalf to satisfy certain withholding and other tax obligations
in connection with an Award, and

 

(3)           
the Company’s imposing sales and transfer procedures and restrictions and hedging restrictions on Shares delivered
under the Plan, and

 

(e)              
any and all consents or authorizations required to comply with, or required to be obtained under, applicable local law or
otherwise required by the Committee. Nothing herein will require the Company to list, register or qualify the Shares on any Applicable
Exchange.

 

		3.4	Right of Offset

 

The Company will have the right to offset
against its obligation to deliver Shares (or other property or cash) under the Plan or any Award Agreement any outstanding amounts
(including, without limitation, travel and entertainment or advance account balances, loans, repayment obligations under any Awards,
or amounts repayable to the Company pursuant to tax equalization, housing, automobile or other employee programs) that the Grantee
then owes to the Company or any of its Subsidiaries or Affiliates and any amounts the Committee otherwise deems appropriate pursuant
to any tax equalization policy or agreement.

 

		3.5	Nonassignability; No Hedging

 

Subject to Section 1.9 and unless
otherwise provided in an Award Agreement or written Company policy, or with the consent of the Committee in its sole discretion,
no Award (or any rights and obligations thereunder) granted to any person under the Plan may be sold, exchanged, transferred, assigned,
pledged, hypothecated or otherwise disposed of or hedged, in any manner (including through the use of any cash-settled instrument),
whether voluntarily or involuntarily and whether by operation of law or otherwise, other than by will or by the laws of descent
and distribution, and all such Awards (and any rights thereunder) will be exercisable during the life of the Grantee only by the
Grantee or the Grantee’s legal representative (it being understood that the term “Grantee” includes such legal
representative and other permitted transferee; provided, that the phrase “termination of Employment” and similar
terms shall continue to refer to the termination of Employment with respect to the original participant). Any sale, exchange, transfer,
assignment, pledge, hypothecation, or other disposition in violation of the provisions of this Section 3.5 will be null
and void and any Award which is hedged in any manner will immediately be forfeited. All of the terms and conditions of the Plan
and the Award Agreements will be binding upon any permitted successors and assigns.

 

    14

     

    

 

		3.6	Change in Control

 

In the event of a Change in Control and
unless otherwise provided in the Award Agreement with respect to a particular Award, a Grantee’s Award will be treated, to
the extent determined by the Committee to be permitted under applicable tax law, in accordance with one or more of the following
methods as determined by the Committee in its sole discretion:

 

(a)              
settle such Awards for an amount (as determined in the sole discretion of the Committee) of cash or securities equal to
their value, where in the case of share options, the value of such amount, if any, will be equal to the in-the-money spread value
(if any) of such awards;

 

(b)               
provide for the assumption of or the issuance of substitute awards that will substantially preserve the otherwise applicable
terms of any affected Awards previously granted under the Plan, as determined by the Committee in its sole discretion;

 

(c)              
modify the terms of such awards to add events, conditions or circumstances upon which the vesting of such Awards or lapse
of restrictions thereon will accelerate;

 

(d)             
deem any performance conditions satisfied at target, maximum or actual performance through closing or provide for the performance
conditions to continue (as is or as adjusted by the Committee) after closing; or

 

(e)              
provide that for a period of at least 20 days prior to the Change in Control, any share options that would not otherwise
become exercisable prior to the Change in Control will be exercisable as to all Shares subject thereto (but any such exercise will
be contingent upon and subject to the occurrence of the Change in Control and if the Change in Control does not take place within
a specified period after giving such notice for any reason whatsoever, the exercise will be null and void) and that any share options
not exercised prior to the consummation of the Change in Control will terminate and be of no further force and effect as of the
consummation of the Change in Control.

 

In the event that the consideration paid
in the Change in Control includes contingent value rights, earnout or indemnity payments or similar payments, then the Committee
will determine if Awards settled under clause (a) above are (i) valued at closing taking into account such contingent consideration
(with the value determined by the Committee in its sole discretion) or (ii) entitled to a share of such contingent consideration.
For the avoidance of doubt, in the event of a Change in Control where all share options are settled for an amount (as determined
in the sole discretion of the Committee) of cash or securities, the Committee may, in its sole discretion, terminate any share
option for which the exercise price is equal to or exceeds the per share value of the consideration to be paid in the Change in
Control transaction without payment of consideration therefor. Similar actions to those specified in this Section 3.6 may
be taken in the event of a merger or other corporate reorganization that does not constitute a Change in Control.

 

		3.7	No Continued Employment or Engagement; Right of Discharge Reserved

 

Neither the adoption of the Plan nor the
grant of any Award (or any provision in the Plan or Award Agreement) will confer upon any Grantee any right to continued Employment,
or other engagement, with the Company or any of its Subsidiaries or Affiliates, nor will it interfere in any way with the right
of the Company or any of its Subsidiaries or Affiliates to terminate, or alter the terms and conditions of, such Employment or
other engagement at any time.

 

    15

     

    

 

		3.8	Nature of Payments

 

		3.8.1	Any and all grants of Awards and deliveries of Shares, cash, securities or other property under the Plan will be in consideration
of services performed or to be performed for the Company by the Grantee. Awards under the Plan may, in the discretion of the Committee,
be made in substitution in whole or in part for cash or other compensation otherwise payable to a Grantee. Only whole Shares will
be delivered under the Plan. Awards will be aggregated in order to eliminate any fractional shares.

 

		3.8.2	All such grants and deliveries of Shares, cash, securities or other property under the Plan will constitute a special discretionary
incentive payment to the Grantee, will not entitle the Grantee to the grant of any future Awards and will not be required to be
taken into account in computing the amount of salary or compensation of the Grantee for the purpose of determining any contributions
to or any benefits under any pension, retirement, profit-sharing, bonus, life insurance, severance or other benefit plan of the
Company or under any agreement with the Grantee, unless the Company specifically provides otherwise.

 

		3.9	Non-Uniform Determinations

 

		3.9.1	The Committee’s determinations under the Plan and Award Agreements need not be uniform and any such determinations may
be made by it selectively among persons who receive, or are eligible to receive, Awards under the Plan (whether or not such persons
are similarly situated). Without limiting the generality of the foregoing, the Committee will be entitled, among other things,
to make non-uniform and selective determinations under Award Agreements, and to enter into non-uniform and selective Award Agreements,
as to (a) the persons to receive Awards, (b) the terms and provisions of Awards and (c) whether a Grantee’s Employment has
been terminated for purposes of the Plan.

 

		3.9.2	To the extent the Committee deems it necessary, appropriate or desirable to comply with local law or practices in the jurisdiction
in which the Grantees are located and to further the purposes of the Plan, the Committee may, in its sole discretion and without
amending the Plan, establish special rules applicable to Awards to Grantees who are foreign nationals, are employed outside Germany,
or who are not compensated from a payroll maintained in Germany, or who are otherwise subject to (or could cause the Company to
be subject to) legal or regulatory provisions of countries or jurisdictions outside Germany, on such terms and conditions different
from those specified in this Plan as may, in the judgment of the Committee, be necessary or desirable to foster and promote achievement
of the purposes of this Plan, and, in furtherance of such purposes, the Committee may make such modifications, amendments, procedures
or subplans as may be necessary or advisable to comply with such legal or regulatory provisions, and grant Awards (or amend existing
Awards) in accordance with those rules.

 

		3.10	Other Payments or Awards

 

Nothing contained in the Plan will be deemed
in any way to limit or restrict the Company from making any award or payment to any person under any other plan, arrangement or
understanding, whether now existing or hereafter in effect.

 

		3.11	Plan Headings

 

The headings in the Plan are for the purpose
of convenience only and are not intended to define or limit the construction of the provisions hereof.

 

    16

     

    

 

		3.12	Termination of Plan

 

The Supervisory Board reserves the right
to terminate the Plan at any time; provided, that in any case, the Plan will terminate one day before the tenth anniversary
of the Effective Date; provided, further, that all Awards made under the Plan before its termination will remain
in effect until such Awards have been satisfied or terminated in accordance with the terms and provisions of the Plan and the applicable
Award Agreements.

 

		3.13	Clawback Policy

 

Awards under the Plan will be subject to
any clawback policy that the Company may adopt from time to time in order to comply with applicable law or the listing standards
of the Applicable Exchange and, in accordance with such policy, may be subject to the requirement that the Awards (or any proceeds
therefrom) be repaid to the Company after they have been distributed to the Grantee, subject in all cases to applicable law. Any
Award granted under the Plan is exclusively aimed at supporting the Grantee’s loyalty with the Company or any of its Subsidiaries
or Affiliates through participation in the Plan and such Award, and is in no way intended to compensate the Grantee for the Grantee’s
employment or service rendered to the Company or any of its Subsidiaries or Affiliates.

 

		3.14	Governing Law

 

THE PLAN AND ALL AWARDS MADE AND ACTIONS
TAKEN THEREUNDER WILL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF GERMANY, WITHOUT REFERENCE TO PRINCIPLES OF CONFLICT
OF LAWS.

 

		3.15	Disputes; Choice of Forum

 

		3.15.1	The Company and each Grantee, as a condition to such Grantee’s participation in the Plan, hereby irrevocably submit to
the exclusive jurisdiction and venue of a competent court in Munich, Germany. The Company and each Grantee, as a condition to such
Grantee’s participation in the Plan, acknowledge that the forum designated by this Section 3.15.1 has a reasonable
relation to the Plan and to the relationship between such Grantee and the Company. Notwithstanding the foregoing, nothing herein
will preclude the Company from bringing any action or proceeding in any other court for the purpose of enforcing the provisions
of this Section 3.15.1.

 

		3.15.2	Each Grantee, as a condition to such Grantee’s participation in the Plan, agrees to keep confidential the existence of,
and any information concerning, a dispute, controversy or claim described in Section 3.16, except that a Grantee may disclose
information concerning such dispute, controversy or claim to the court that is considering such dispute, controversy or claim or
to such Grantee’s legal counsel (provided that such counsel agrees not to disclose any such information other than as necessary
to the prosecution or defense of the dispute, controversy or claim).

 

		3.16	Waiver of Claims

 

Each Grantee of
an Award recognizes and agrees that before being selected by the Committee to receive an Award the Grantee has no right to
any benefits under the Plan. Accordingly, in consideration of the Grantee’s receipt of any Award hereunder, the Grantee
expressly waives any right to contest the amount of any Award, the terms of any Award Agreement, any determination, action or
omission hereunder or under any Award Agreement by the Committee, the Company or the Supervisory Board or the Management
Board, or any amendment to the Plan or any Award Agreement (other than an amendment to the Plan or an Award Agreement to
which his or her consent is expressly required by the express terms of an Award Agreement). Nothing contained in the Plan,
and no action taken pursuant to its provisions, will create or be construed to create a trust of any kind or a fiduciary
relationship between the Company and any Grantee.

 

    17

     

    

 

		3.17	Severability; Entire Agreement

 

If any of the provisions of the Plan or
any Award Agreement is finally held to be invalid, illegal or unenforceable (whether in whole or in part), such provision will
be deemed modified to the extent, but only to the extent, of such invalidity, illegality or unenforceability and the remaining
provisions will not be affected thereby; provided, that if any of such provisions is finally held to be invalid, illegal,
or unenforceable because it exceeds the maximum scope determined to be acceptable to permit such provision to be enforceable, such
provision will be deemed to be modified to the minimum extent necessary to modify such scope in order to make such provision enforceable
hereunder. The Plan and any Award Agreements contain the entire agreement of the parties with respect to the subject matter thereof
and supersede all prior agreements, promises, covenants, arrangements, communications, representations and warranties between them,
whether written or oral with respect to the subject matter thereof.

 

		3.18	No Liability of Company

 

Notwithstanding anything to the contrary
contained herein, in no event will the Company be liable to a Grantee on account of: (a) an Award’s failure to (1) qualify
for favorable tax treatment in the jurisdiction in which the Grantee is located or (2) avoid adverse tax treatment in the jurisdiction
in which the Grantee is located, or (b) the non-issuance or sale of Shares as to which the Company has been unable to obtain from
any regulatory body having jurisdiction the authority deemed by the Company’s counsel to be necessary to the lawful issuance
and sale of any Shares hereunder.

 

		3.19	No Third-Party Beneficiaries

 

Except as expressly provided in an Award
Agreement, neither the Plan nor any Award Agreement will confer on any person other than the Company and the Grantee of any Award
any rights or remedies thereunder. The exculpation and indemnification provisions of Section 1.3.5 will inure to the benefit
of a Covered Person’s estate and beneficiaries and legatees.

 

		3.20	Unfunded Status of Plan

 

It is intended that this Plan constitute
an “unfunded” plan. The Committee may authorize the creation of trusts or other arrangements to meet the obligations
created under this Plan to deliver Shares or make payments; provided, that the existence of such trusts or other arrangements
is consistent with the “unfunded” status of this Plan.

 

		3.21	Expenses

 

The expenses of administering the Plan shall
be borne by the Company or its Subsidiaries or Affiliates.

 

		3.22	Relationship to Other Benefits

 

No Award or payment under the Plan shall
be taken into account in determining any benefits under any pension, retirement, profit sharing, group insurance or other benefit
plan of the Company or any of its Subsidiaries or Affiliates, except as otherwise specifically provided in such other plan or as
required by applicable law

 

    18

     

    

 

		3.23	Successors and Assigns of the Company

 

The terms of the Plan will be binding upon
and inure to the benefit of the Company and any successor entity, including as contemplated by Section 3.6.

 

		3.24	Date of Adoption

 

The Plan was adopted by the Supervisory
Board and by the general meeting of the Company on December 17, 2020 (the “Effective Date”). The Plan shall
be submitted to the Management Board for adoption as soon as practicable following the Effective Date and, to the extent applicable
in connection with an IPO, in no event later than the date on which the public offering price in the IPO is determined by the Company
and the managing underwriters.

 

    19

     

    

 

APPENDIX A

TO

MYT NETHERLANDS PARENT B.V.

2020
OMNIBUS INCENTIVE PLAN

 

(for United States taxpayers only)

 

The provisions of this Appendix A shall form a part of
the MYT Netherlands Parent B.V. 2020 Omnibus Incentive Compensation Plan, as amended from time to time (the “Plan”),
the terms of which are incorporated herein by reference. Capitalized terms not defined herein shall have the meanings set forth
in the Plan.

 

1.                 
Applicability.

 

The purpose of this Appendix A is to establish certain
rules and limitations applicable to Awards that may be granted or issued under the Plan from time to time, in compliance with the
United States federal income taxation applicable laws currently in force in the United States.

 

This Appendix A applies to any Grantee who is subject
to income taxation under the federal tax laws of the United States as a resident or non-resident of the United States (a “U.S.
Grantee”). This Appendix A shall be deemed to be part of the Plan and all of the provisions of the Plan shall
apply to this Appendix A, and where any terms of this Appendix A are in conflict with the Plan, the terms of this
Appendix A shall control.

 

Notwithstanding any provisions contained in the Plan to the
contrary and to the extent required by applicable laws, the terms set forth in this Appendix A shall apply to all Awards
granted to U.S. Grantees.

 

2.                 
Definitions. The following additional definitions will apply to grants made to U.S. Grantees:

 

(a)               
“Code” means the Internal Revenue Code of 1986, as amended from time to time, or any successor
thereto, and the applicable rulings and regulations thereunder.

 

(b)               
“Incentive Share Option” means a share option to purchase Shares that is intended to be an “incentive
stock option” within the meaning of Sections 421 and 422 of the Code, as now constituted or subsequently amended, or pursuant
to a successor provision of the Code, and which is designated as an Incentive Share Option in the applicable Award Agreement.

 

(c)               
“Section 409A” means Section 409A of the Code, including any amendments or successor provisions
to that section, and any regulations and other administrative guidance thereunder, in each case as they may be from time to time
amended or interpreted through further administrative guidance.

 

(d)               
“Ten Percent Shareholder” means a person owning shares possessing more than 10% of the total combined
voting power of all classes of share of the Company and of any Subsidiary or parent corporation of the Company.

 

(e)               
“Treasury Regulations” means the regulations promulgated under the Code by the United States Treasury
Department, as amended.

 

3.                 
Adjustments. The adjustments under Section 1.6.3 of the Plan shall apply to the number of Shares set
forth in Section 4(a) hereof that can be issued through Incentive Share Options.

 

    A-1

     

    

 

4.                 
Incentive Share Options.

 

(a)               
 No more than a total number of Shares equal to 13.75% of the outstanding share capital of the Company on the Effective
Date (as adjusted pursuant to the provisions of Section 1.6.3 of the Plan) that can be delivered under the Plan may be issued
through Incentive Share Options. Incentive Share Options may not be granted under the Plan after the tenth anniversary of the date
of the Committee’s most recent approval thereof.

 

 

(b)               
With respect to any share options granted to a U.S. Grantee, at the time of grant, the Committee will determine:

 

(1)                       
whether all or any part of a share option granted to an eligible Employee will be an Incentive Share Option, and

 

(2)                       
the number of Shares subject to such Incentive Share Option; provided, that

 

(A)             
the aggregate Fair Market Value (determined as of the time the option is granted) of the share with respect to which Incentive
Share Options are exercisable for the first time by an eligible Employee during any calendar year (under all such plans of the
Company and of any Subsidiary or parent corporation of the Company) may not exceed $100,000 and

 

(B)             
no Incentive Share Option (other than an Incentive Share Option that may be assumed or issued by the Company in connection
with a transaction to which Section 424(a) of the Code applies) may be granted to a person who is not eligible to receive an Incentive
Share Option under the Code.

 

The form of any share option which is entirely
or in part an Incentive Share Option will clearly indicate that such share option is an Incentive Share Option or, if applicable,
the number of Shares subject to the Incentive Share Option.

 

(c)               
The exercise price per share with respect to each share option will be determined by the Committee pursuant to Section
2.3.2 of the Plan, but, except as otherwise permitted by Section 1.6.3 of the Plan and except for any Acquisition Awards,
may never be less than the Fair Market Value of a Share (or, in the case of an Incentive Share Option granted to a Ten Percent
Shareholder, 110% of the Fair Market Value).

 

(d)               
In no event will any share option be exercisable after the expiration of 10 years (or, in the case of an Incentive Share
Option granted to a Ten Percent Shareholder, 5 years) from the date on which the share option is granted.

 

5.                 
Amendment of the Plan. Notwithstanding any provision of Section 3.1.2 of the Plan to the contrary,
if and to the extent the Supervisory Board determines it is appropriate for the Plan to comply with the provisions of Section 422
of the Code, no amendment that would require shareholder approval under Section 422 of the Code will be effective without the approval
of the Company’s shareholders.

 

6.                 
Right of Offset. Notwithstanding any provision of Section 3.4 of the Plan to the contrary, if an Award
provides for the deferral of compensation within the meaning of Section 409A, the Committee will have no right to offset against
its obligation to deliver Shares (or other property or cash) under the Plan or any Award Agreement if such offset could subject
the Grantee to the additional tax imposed under Section 409A in respect of an outstanding Award.

 

    A-2

     

    

 

7.                 
Section 409A.

 

(a)              
 All Awards made under the Plan that are intended to be “deferred compensation” subject to Section 409A will
be interpreted, administered and construed to comply with Section 409A, and all Awards made under the Plan that are intended to
be exempt from Section 409A will be interpreted, administered and construed to comply with and preserve such exemption. The Committee,
the Supervisory Board and the Management Board will have full authority to give effect to the intent of the foregoing sentence.
To the extent necessary to give effect to this intent, in the case of any conflict or potential inconsistency between the Plan
and a provision of any Award or Award Agreement with respect to an Award, the Plan will govern.

 

(b)              
Without limiting the generality of Section 7(a) hereof, with respect to any Award made under the Plan that is intended
to be “deferred compensation” subject to Section 409A:

 

(1)                       
any payment due upon a Grantee’s termination of Employment will be paid only upon such Grantee’s “separation
from service” (within the meaning of Section 409A);

 

(2)                       
any payment due upon a Change in Control of the Company will be paid only if such Change in Control constitutes a “change
in ownership” or “change in effective control” within the meaning of Section 409A, and in the event that such
Change in Control does not constitute a “change in the ownership” or “change in the effective control”
within the meaning of Section 409A, such Award will vest upon the Change in Control and any payment will be delayed until the first
compliant date under Section 409A;

 

(3)                       
to the extent necessary to avoid the imposition of taxes under Section 409A, any such payment to a specified employee (as
determined in accordance with Section 409A of the Code) to be made with respect to such Award in connection with such Grantee’s
separation from service from the Company within the meaning of Section 409A (and any other payment that would be subject to the
limitations in Section 409A(a)(2)(B) of the Code) will be delayed until six months after such Grantee’s separation from service
(or earlier death) in accordance with the requirements of Section 409A;

 

(4)                       
to the extent necessary to comply with Section 409A, any other securities, other Awards or other property that the Company
may deliver in lieu of Shares in respect of an Award will not have the effect of deferring delivery or payment beyond the date
on which such delivery or payment would occur with respect to the Shares that would otherwise have been deliverable (unless the
Committee elects a later date for this purpose in accordance with the requirements of Section 409A);

 

(5)                       
with respect to any required Consent described in Section 3.3 of the Plan or the applicable Award Agreement, if such
Consent has not been effected or obtained as of the latest date provided by such Award Agreement for payment in respect of such
Award and further delay of payment is not permitted in accordance with the requirements of Section 409A, such Award or portion
thereof, as applicable, will be forfeited and terminate notwithstanding any prior earning or vesting;

 

(6)                       
if the Award includes a “series of installment payments” (within the meaning of Section 1.409A-2(b)(2)(iii)
of the Treasury Regulations), the Grantee’s right to the series of installment payments will be treated as a right to a series
of separate payments and not as a right to a single payment; and

 

(7)                        for
purposes of determining whether the Grantee has experienced a separation from service from the Company within the meaning of
Section 409A, “subsidiary” will mean a corporation or other entity in a chain of corporations or other entities
in which each corporation or other entity, starting with the Company, has a controlling interest in another corporation or
other entity in the chain, ending with such corporation or other entity. For purposes of the preceding sentence, the term
 “controlling interest” has the same meaning as provided in Section 1.414(c)-2(b)(2)(i) of the Treasury
Regulations, provided that, subject to compliance with Section 409A, the language “at least 20 percent” may be
used instead of “at least 80 percent” each place it appears in Section 1.414(c)-2(b)(2)(i) of the Treasury
Regulations.

 

    A-3

     

    

 

8.                 
Section 457A. This Plan and the Awards are not intended to be subject to Section 457A of the Code. Notwithstanding
any other provision of this Plan, if this Plan or any Award is subject to Section 457A of the Code, each of the Committee, the
Supervisory Board and the Management Board, as applicable, reserves the authority to amend this Plan or any Award or adopt other
policies or procedures or take any other actions, including amendments or actions that would result in a reduction to the benefits
payable under an Award that the Committee, the Supervisory Board and the Management Board, respectively, deems necessary or appropriate
to exempt the Award from Section 457A of the Code and/or preserve the intended tax treatment of the benefits provided with respect
to the Award or mitigate any additional tax, interest and/or penalties or other adverse tax consequences that may apply under Section
457A of the Code if an exemption is not available.

 

9.                 
Section 280G. In the event that any payments or benefits otherwise payable to a Grantee (1) constitute “parachute
payments” within the meaning of Section 280G of the Code, and (2) but for this Section 9, would be subject to the
excise tax imposed by Section 4999 of the Code, then such payments and benefits will be either (x) delivered in full, or (y) delivered
as to such lesser extent that would result in no portion of such payments and benefits being subject to excise tax under Section
4999 of the Code, whichever of the foregoing amounts, taking into account the applicable United States federal, state and local
income and employment taxes and the excise tax imposed by Section 4999 of the Code (and any equivalent state or local excise taxes),
results in the receipt by Grantee on an after-tax basis, of the greatest amount of benefits, notwithstanding that all or some portion
of such payments and benefits may be taxable under Section 4999 of the Code. Any determination required under this Section 9
will be made in writing by a nationally-recognized firm selected by the Company, whose determination will be conclusive and binding
upon the Grantee. Any reduction in payments and/or benefits required by this provision will occur in the following order: (1) reduction
of cash payments; (2) reduction of vesting acceleration of equity awards; and (3) reduction of other benefits paid or provided
to the Grantee. In the event that acceleration of vesting of equity awards under the Plan is to be reduced, such acceleration of
vesting will be cancelled in the reverse order of the date of grant for equity awards. If two or more equity awards are granted
on the same date, each award will be reduced on a pro-rata basis.

 

10.              
Status of Plan. The Plan is not intended to be subject to the Employee Retirement Income Security Act of 1974,
as amended.

 

    A-4Exhibit
4.1

 

WARRANT
AGREEMENT

 

THIS
WARRANT AGREEMENT (this “Agreement”), dated as of January 11, 2021 is by and between Big Cypress
Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust
Company, a New York corporation, as warrant agent (the “Warrant Agent”, also referred to herein as the
“Transfer Agent”).

 

WHEREAS,
the Company is engaged in an initial public offering (the “Offering”) of units of the Company’s
equity securities, each such unit comprised of one share of common stock of the Company, par value $0.0001 per share (“Common
Stock”) and one-half of one redeemable Public Warrant (as defined below) (the “Units”)
and, in connection therewith, has determined to issue and deliver up to 5,000,000 warrants (or up to 5,750,000 warrants if the
Over-Allotment Option (as defined below) is exercised in full) to public investors in the Offering (the “Public Warrants”);
and

 

WHEREAS,
on January 11, 2021 the Company entered into a Units Subscription Agreement with Big Cypress Holdings LLC, a Delaware limited
liability company (the “Sponsor”), pursuant to which the Sponsor agreed to purchase an aggregate of
382,250 Units (or up to 417,200 Units if the Over-Allotment Option is exercised in full) simultaneously with the closing of the
Offering at a purchase price of $10.00 per Unit and in connection therewith, will issue and deliver up to an aggregate of 191,125
warrants (or up to 208,599 warrants if the Over-Allotment Option is exercised in full) bearing the legend set forth in Exhibit
B hereto (“Private Placement Warrants”); and

 

WHEREAS,
in order to finance the Company’s transaction costs in connection with an intended initial Business Combination (as defined
below), the Sponsor or an affiliate of the Sponsor or certain of the Company’s executive officers and directors may, but
are not obligated to, loan to the Company funds as the Company may require, of which up to $1,500,000 of such loans may be convertible
into up to an additional 150,000 Units at a price of $10.00 per Unit, and in connection therewith, will issue and deliver up to
an aggregate of 75,000 warrants (the “Working Capital Warrants”); and

 

WHEREAS,
following consummation of the Offering, the Company may issue additional warrants (“Post-IPO Warrants”;
together with the Private Placement Warrants, the Working Capital Warrants and the Public Warrants, the “Warrants”)
in connection with, or following the consummation by the Company of, a Business Combination (defined below); and

 

WHEREAS,
the Company has filed with the Securities and Exchange Commission (the “Commission”) a registration
statement on Form S-1, File No. 333-251178 (the “Registration Statement”) and prospectus (the “Prospectus”),
for the registration, under the Securities Act of 1933, as amended (the “Securities Act”), of the Units,
the Public Warrants and the Common Stock included in the Units; and

 

WHEREAS,
the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection
with the issuance, registration, transfer, exchange, redemption and exercise of the Warrants; and

 

WHEREAS,
the Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised,
and the respective rights, limitation of rights, and immunities of the Company, the Warrant Agent, and the holders of the Warrants;
and

 

WHEREAS,
all acts and things have been done and performed which are necessary to make the Warrants, when executed on behalf of the Company
and countersigned by or on behalf of the Warrant Agent, as provided herein, the valid, binding and legal obligations of the Company,
and to authorize the execution and delivery of this Agreement.

 

    	1

     

    

 

NOW,
THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

 

1.
Appointment of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants,
and the Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions
set forth in this Agreement.

 

2.
Warrants.

 

2.1
Form of Warrant. Each Warrant shall be issued in registered form only, and, if a physical certificate is issued, shall
be in substantially the form of Exhibit A hereto, the provisions of which are incorporated herein and shall be signed by,
or bear the facsimile signature of, the Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer, Secretary
or other principal officer of the Company. In the event the person whose facsimile signature has been placed upon any Warrant
shall have ceased to serve in the capacity in which such person signed the Warrant before such Warrant is issued, it may be issued
with the same effect as if he or she had not ceased to be such at the date of issuance.

 

2.2
Effect of Countersignature. If a physical certificate is issued, unless and until countersigned by the Warrant Agent pursuant
to this Agreement, a Warrant certificate shall be invalid and of no effect and may not be exercised by the holder thereof.

 

2.3
Registration.

 

2.3.1
Warrant Register. The Warrant Agent shall maintain books (the “Warrant Register”) for the registration
of original issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant
Agent shall issue and register the Warrants in the names of the respective holders thereof in such denominations and otherwise
in accordance with instructions delivered to the Warrant Agent by the Company. All of the Public Warrants shall initially be represented
by one or more book-entry certificates (each, a “Book-Entry Warrant Certificate”) deposited with The
Depository Trust Company (the “Depositary”) and registered in the name of Cede & Co., a nominee
of the Depositary. Ownership of beneficial interests in the Public Warrants shall be shown on, and the transfer of such ownership
shall be effected through, records maintained by (i) the Depositary or its nominee for each Book-Entry Warrant Certificate, or
(ii) institutions that have accounts with the Depositary (each such institution, with respect to a Warrant in its account, a “Participant”).

 

If
the Depositary subsequently ceases to make its book-entry settlement system available for the Public Warrants, the Company may
instruct the Warrant Agent regarding making other arrangements for book-entry settlement. In the event that the Public Warrants
are not eligible for, or it is no longer necessary to have the Public Warrants available in, book-entry form, the Warrant Agent
shall provide written instructions to the Depositary to deliver to the Warrant Agent for cancellation each Book-Entry Warrant
Certificate, and the Company shall instruct the Warrant Agent to deliver to the Depositary definitive certificates in physical
form evidencing such Warrants (“Definitive Warrant Certificate”). Such Definitive Warrant Certificate
shall be in the form annexed hereto as Exhibit A, with appropriate insertions, modifications and omissions, as provided
above.

 

2.3.2
Registered Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent
may deem and treat the person in whose name such Warrant is registered in the Warrant Register (the “Registered Holder”)
as the absolute owner of such Warrant and of each Warrant represented thereby (notwithstanding any notation of ownership or other
writing on a Definitive Warrant Certificate made by anyone other than the Company or the Warrant Agent), for the purpose of any
exercise thereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to
the contrary.

 

2.4
Detachability of Warrants. The Common Stock and Public Warrants comprising the Units shall begin separate trading on the
52nd day following the date of the Prospectus or, if such 52nd day is not on a day, other than a Saturday, Sunday or federal holiday,
on which banks in New York City are generally open for normal business (a “Business Day”), then on the
immediately succeeding Business Day following such date, or earlier (the “Detachment Date”) with the
consent of Ladenburg Thalmann & Co. Inc., as representative of the several underwriters (the “Representative”),
but in no event shall the Common Stock and the Public Warrants comprising the Units be separately traded until (A) the Company
has filed a current report on Form 8-K with the Commission containing an audited balance sheet reflecting the receipt by the Company
of the gross proceeds of the Offering, including the proceeds received by the Company from the exercise by the underwriters of
their right to purchase additional Units in the Offering (the “Over-Allotment Option”), if the Over-Allotment
Option is exercised prior to the filing of the current report on Form 8-K, and (B) the Company issues a press release and files
with the Commission a current report on Form 8-K announcing when such separate trading shall begin.

 

    	2

     

    

 

2.5
No Fractional Warrants Other Than as Part of Units. The Company shall not issue fractional Warrants other than as part
of the Units, each of which is comprised of one share of Common Stock and one-half of one Public Warrant. If, upon the detachment
of Public Warrants from Units or otherwise, a holder of Warrants would be entitled to receive a fractional Warrant, the Company
shall round down to the nearest whole number the number of Warrants to be issued to such holder.

 

2.6
Private Placement Warrants and Working Capital Warrants. The Private Placement Warrants and the Working Capital Warrants
shall be identical to the Public Warrants, except that so long as they are held by the Sponsor or any Permitted Transferees (as
defined below), as applicable, the Private Placement Warrants and the Working Capital Warrants: (i) may be exercised for cash
or on a cashless basis, pursuant to subsection 3.3.1(c) hereof, (ii) may not be transferred, assigned or sold until thirty
(30) days after the completion by the Company of an initial Business Combination (as defined below), and (iii) shall not be redeemable
by the Company; provided, however, that in the case of (ii) the Private Placement Warrants and the Working Capital
Warrants and any shares of Common Stock held by the Sponsor or any Permitted Transferees, as applicable, and issued upon exercise
of the Private Placement Warrants and the Working Capital Warrants may be transferred by the holders thereof:

 

(a)
to the Company’s officers or directors, any affiliate or family member of any of the Company’s officers or directors,
any affiliate of the Sponsor or to any member(s) of the Sponsor or any of their affiliates, officers, directors and direct and
indirect equityholders;

 

(b)
in the case of an individual, by gift to a member such individual’s immediate family or to a trust, the beneficiary of which
is a member of such individual’s immediate family, an affiliate of such individual or to a charitable organization;

 

(c)
in the case of an individual, by virtue of the laws of descent and distribution upon death of any of our officers, our directors,
the initial stockholders, or members of our sponsor or any of their affiliates;

 

(d)
in the case of an individual, pursuant to a qualified domestic relations order;

 

(e)
by private sales or transfers made in connection with the consummation of an initial Business Combination at prices no greater
than the price at which the Warrants were originally purchased or otherwise with the consent of the Company;

 

(f)
in the event of the Company’s liquidation prior to consummation of the Company’s Business Combination; or

 

(g)
by virtue of the laws of the State of Delaware or the Sponsor’s limited liability company agreement upon dissolution of
the Sponsor; provided, however, that, in the case of clauses (a) through (e) or (g), these permitted transferees
(the “Permitted Transferees”) must enter into a written agreement with the Company agreeing to be bound
by the transfer restrictions in this Agreement.

 

2.7
Working Capital Warrants. The Working Capital Warrants shall be identical to the Private Placement Warrants.

 

2.8
Post-IPO Warrants. The Post-IPO Warrants, when and if issued, shall have the same terms and be in the same form as the
Public Warrants except as may be agreed upon by the Company.

 

    	3

     

    

 

3.
Terms and Exercise of Warrants.

 

3.1
Warrant Price. Each whole Warrant shall entitle the Registered Holder thereof, subject to the provisions of such Warrant
and of this Agreement, to purchase from the Company the number of shares of Common Stock stated therein, at the price of $11.50
per share, subject to the adjustments provided in Section 4 hereof and in the last sentence of this Section 3.1.
The term “Warrant Price” as used in this Agreement shall mean the price per share at which shares of Common Stock
may be purchased at the time a Warrant is exercised. The Company in its sole discretion may lower the Warrant Price at any time
prior to the Expiration Date (as defined below) for a period of not less than twenty (20) Business Days, provided, that the Company
shall provide at least twenty (20) days prior written notice of such reduction to Registered Holders of the Warrants and, provided
further that any such reduction shall be identical among all of the Warrants.

 

3.2
Duration of Warrants. A Warrant may be exercised only during the period (the “Exercise Period”)
commencing on the later of: (i) the date that is thirty (30) days after the first date on which the Company completes a merger,
capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination, involving the Company
and one or more businesses (a “Business Combination”), or (ii) the date that is twelve (12) months from
the date of the closing of the Offering, and terminating at 5:00 p.m., New York City time on the earlier to occur of: (x) the
date that is five (5) years after the date on which the Company completes its initial Business Combination, (y) the liquidation
of the Company if the Company fails to complete a Business Combination, or (z) other than with respect to the Private Placement
Warrants and the Working Capital Warrants to the extent then held by the original purchasers thereof or their Permitted Transferees,
the Redemption Date (as defined below) as provided in Section 6.2 hereof (the “Expiration Date”);
provided, however, that the exercise of any Warrant shall be subject to the satisfaction of any applicable conditions,
as set forth in subsection 3.3.2 below with respect to an effective registration statement. Except with respect to the
right to receive the Redemption Price (as defined below) (other than with respect to a Private Placement Warrant or a Working
Capital Warrant) to the extent then held by the original purchasers thereof or their Permitted Transferees in the event of a redemption
(as set forth in Section 6 hereof), each outstanding Warrant (other than a Private Placement Warrant or a Working Capital
Warrant to the extent then held by the original purchasers thereof or their Permitted Transferees in the event of a redemption)
not exercised on or before the Expiration Date shall become void, and all rights thereunder and all rights in respect thereof
under this Agreement shall cease at 5:00 p.m. New York City time on the Expiration Date. The Company in its sole discretion may
extend the duration of the Warrants by delaying the Expiration Date; provided, that the Company shall provide at least
twenty (20) days prior written notice of any such extension to Registered Holders of the Warrants and, provided further that any
such extension shall be identical in duration among all the Warrants.

 

3.3
Exercise of Warrants.

 

3.3.1
Payment. Subject to the provisions of the Warrant and this Agreement, a Warrant may be exercised by the Registered Holder
thereof by delivering to the Warrant Agent at its corporate trust department (i) the Definitive Warrant Certificate evidencing
the Warrants to be exercised, or, in the case of a Book-Entry Warrant Certificate, the Warrants to be exercised (the “Book-Entry
Warrants”) on the records of the Depositary to an account of the Warrant Agent at the Depositary designated for
such purposes in writing by the Warrant Agent to the Depositary from time to time, (ii) an election to purchase (“Election
to Purchase”) shares of Common Stock pursuant to the exercise of a Warrant, properly completed and executed by the
Registered Holder on the reverse of the Definitive Warrant Certificate or, in the case of a Book-Entry Warrant Certificate, properly
delivered by the Participant in accordance with the Depositary’s procedures, and (iii) payment in full of the Warrant Price
for each full share of Common Stock as to which the Warrant is exercised and any and all applicable taxes due in connection with
the exercise of the Warrant, the exchange of the Warrant for the shares of Common Stock and the issuance of such shares of Common
Stock, as follows:

 

(a)
by certified check payable to the order of the Warrant Agent or by wire transfer;

 

(b)
in the event of a redemption pursuant to Section 6 hereof in which the Company’s board of directors (the “Board”)
has elected to require all holders of the Warrants to exercise such Warrants on a “cashless basis,” by surrendering
the Warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number
of shares of Common Stock underlying the Warrants, multiplied by the difference between the Warrant Price and the “Fair
Market Value”, as defined in this subsection 3.3.1(b) by (y) the Fair Market Value; provided, however, that no cashless
exercise shall be permitted unless the Fair Market Value is equal to or higher than the Warrant Price. Solely for purposes of
this subsection 3.3.1(b) and Section 6.3, the “Fair Market Value” shall mean the average last sale price
of the Common Stock for the ten (10) trading days ending on the third trading day prior to the date on which the notice of redemption
is sent to the holders of the Warrants, pursuant to Section 6 hereof;

 

    	4

     

    

 

(c)
with respect to any Private Placement Warrant or Working Capital Warrant, so long as such Private Placement Warrant or Working
Capital Warrant is held by the Sponsor or a Permitted Transferee, as applicable, by surrendering the Warrants for that number
of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying
the Warrants, multiplied by the difference between the Warrant Price and the “Fair Market Value”, as defined in this
subsection 3.3.1(c), by (y) the Fair Market Value. Solely for purposes of this subsection 3.3.1(c), the “Fair
Market Value” shall mean the average reported last sale price of the Common Stock for the ten (10) trading days ending on
the third trading day prior to the date on which notice of exercise of the Warrant is sent to the Warrant Agent; or

 

(d)
as provided in Section 7.4 hereof.

 

3.3.2
Issuance of Shares of Common Stock on Exercise. As soon as practicable after the exercise of any Warrant and the clearance
of the funds in payment of the Warrant Price (if payment is pursuant to subsection 3.3.1(a)), the Company shall issue to
the Registered Holder of such Warrant a book-entry position or certificate, as applicable, for the number of full shares of Common
Stock to which he, she or it is entitled, registered in such name or names as may be directed by him, her or it, and if such Warrant
shall not have been exercised in full, a new book-entry position or countersigned Warrant, as applicable, for the number of shares
of Common Stock as to which such Warrant shall not have been exercised. If fewer than all the Warrants evidenced by a Book-Entry
Warrant Certificate are exercised, a notation shall be made to the records maintained by the Depositary, its nominee for each
Book-Entry Warrant Certificate, or a Participant, as appropriate, evidencing the balance of the Warrants remaining after such
exercise. Notwithstanding the foregoing, the Company shall not be obligated to deliver any shares of Common Stock pursuant to
the exercise of a Warrant and shall have no obligation to settle such Warrant exercise unless a registration statement under the
Securities Act with respect to the shares of Common Stock underlying the Public Warrants is then effective and a prospectus relating
thereto is current, subject to the Company’s satisfying its obligations under Section 7.4. No Warrant shall be exercisable
and the Company shall not be obligated to issue shares of Common Stock upon exercise of a Warrant unless the Common Stock issuable
upon such Warrant exercise has been registered, qualified or deemed to be exempt from registration or qualification under the
securities laws of the state of residence of the Registered Holder of the Warrants, except pursuant to Section 7.4. In
the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a Warrant, the holder
of such Warrant shall not be entitled to exercise such Warrant and such Warrant may have no value and expire worthless, in which
case the purchaser of a Unit containing such Public Warrants shall have paid the full purchase price for the Unit solely for the
shares of Common Stock underlying such Unit. In no event will the Company be required to net cash settle the Warrant exercise.
The Company may require holders of Public Warrants to settle the Warrant on a “cashless basis” pursuant to subsection
3.3.1(b) and Section 7.4. If, by reason of any exercise of Warrants on a “cashless basis”, the holder of
any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share of Common Stock,
the Company shall round down to the nearest whole number, the number of shares of Common Stock to be issued to such holder.

 

3.3.3
Valid Issuance. All shares of Common Stock issued upon the proper exercise of a Warrant in conformity with this Agreement
shall be validly issued, fully paid and non-assessable.

 

3.3.4
Date of Issuance. Each person in whose name any book-entry position or certificate, as applicable, for shares of Common
Stock is issued shall for all purposes be deemed to have become the holder of record of such shares of Common Stock on the date
on which the Warrant, or book-entry position representing such Warrant, was surrendered and payment of the Warrant Price was made,
irrespective of the date of delivery of such certificate in the case of a certificated Warrant, except that, if the date of such
surrender and payment is a date when the share transfer books of the Company or book-entry system of the Warrant Agent are closed,
such person shall be deemed to have become the holder of such shares of Common Stock at the close of business on the next succeeding
date on which the share transfer books or book-entry system are open.

 

    	5

     

    

 

3.3.5
Maximum Percentage. A holder of a Warrant may notify the Company in writing in the event it elects to be subject to the
provisions contained in this subsection 3.3.5; however, no holder of a Warrant shall be subject to this subsection
3.3.5 unless he, she or it makes such election. If the election is made by a holder, the Warrant Agent shall not effect the
exercise of the holder’s Warrant, and such holder shall not have the right to exercise such Warrant, to the extent that
after giving effect to such exercise, such person (together with such person’s affiliates), to the Warrant Agent’s
actual knowledge, would beneficially own in excess of 4.9% or 9.8% (or such other amount as a holder may specify)(the “Maximum
Percentage”) of the shares of Common Stock outstanding immediately after giving effect to such exercise. For purposes
of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by such person and its affiliates
shall include the number of shares of Common Stock issuable upon exercise of the Warrant with respect to which the determination
of such sentence is being made, but shall exclude shares of Common Stock that would be issuable upon (x) exercise of the remaining,
unexercised portion of the Warrant beneficially owned by such person and its affiliates and (y) exercise or conversion of the
unexercised or unconverted portion of any other securities of the Company beneficially owned by such person and its affiliates
(including, without limitation, any convertible notes or convertible preferred stock or warrants) subject to a limitation on conversion
or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this
paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”). For purposes of the Warrant, in determining the number of outstanding
shares of Common Stock, the holder may rely on the number of outstanding shares of Common Stock as reflected in (1) the Company’s
most recent annual report on Form 10-K, quarterly report on Form 10-Q, current report on Form 8-K or other public filing with
the Commission as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company
or the Transfer Agent setting forth the number of shares of Common Stock outstanding. For any reason at any time, upon the written
request of the holder of the Warrant, the Company shall, within two (2) Business Days, confirm orally and in writing to such holder
the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be
determined after giving effect to the conversion or exercise of equity securities of the Company by the holder and its affiliates
since the date as of which such number of outstanding shares of Common Stock was reported. By written notice to the Company, the
holder of a Warrant may from time to time increase or decrease the Maximum Percentage applicable to such holder to any other percentage
specified in such notice; provided, however, that any such increase shall not be effective until the sixty-first
(61st) day after such notice is delivered to the Company.

 

4.
Adjustments.

 

4.1
Stock Dividends.

 

4.1.1
Split-Ups. If after the date hereof, and subject to the provisions of Section 4.6 below, the number of outstanding
shares of Common Stock is increased by a stock dividend payable in shares of Common Stock, or by a split-up of shares of Common
Stock or other similar event, then, on the effective date of such stock dividend, split-up or similar event, the number of shares
of Common Stock issuable on exercise of each Warrant shall be increased in proportion to such increase in the outstanding shares
of Common Stock. A rights offering to holders of the Common Stock entitling holders to purchase shares of Common Stock at a price
less than the “Fair Market Value” (as defined below) shall be deemed a stock dividend of a number of shares of Common
Stock equal to the product of (i) the number of shares of Common Stock actually sold in such rights offering (or issuable under
any other equity securities sold in such rights offering that are convertible into or exercisable for the Common Stock) and (ii)
one (1) minus the quotient of (x) the price per share of Common Stock paid in such rights offering divided by (y) the Fair Market
Value. For purposes of this subsection 4.1.1, (i) if the rights offering is for securities convertible into or exercisable
for Common Stock, in determining the price payable for Common Stock, there shall be taken into account any consideration received
for such rights, as well as any additional amount payable upon exercise or conversion and (ii) “Fair Market Value”
means the volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading
day prior to the first date on which the shares of Common Stock trade on the applicable exchange or in the applicable market,
regular way, without the right to receive such rights.

 

    	6

     

    

 

4.1.2
Extraordinary Dividends. If the Company, at any time while the Warrants are outstanding and unexpired, shall pay a dividend
or make a distribution in cash, securities or other assets to the holders of the Common Stock on account of such shares of Common
Stock (or other shares of the Company’s capital stock into which the Warrants are convertible), other than (a) as described
in subsection 4.1.1 above, (b) Ordinary Cash Dividends (as defined below), (c) to satisfy the redemption rights of the
holders of the Common Stock in connection with a proposed initial Business Combination, (d) as a result of the repurchase of shares
of Common Stock by the Company if a proposed Business Combination is presented to the stockholders of the Company for approval,
(e) to satisfy the redemption rights of the holders of Common Stock in connection with a stockholder vote to amend the Company’s
amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem
100% of the public shares of Common Stock if the Company does not complete the Business Combination within the period set forth
in the Company’s amended and restated certificate of incorporation or (f) in connection with the redemption of public shares
of Common Stock upon the failure of the Company to complete its initial Business Combination and any subsequent distribution of
its assets upon its liquidation (any such non-excluded event being referred to herein as an “Extraordinary Dividend”),
then the Warrant Price shall be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the
amount of cash and/or the fair market value (as determined by the Board, in good faith) of any securities or other assets paid
on each share of Common Stock in respect of such Extraordinary Dividend. For purposes of this subsection 4.1.2, “Ordinary
Cash Dividends” means any cash dividend or cash distribution which, when combined on a per share basis, with the
per share amounts of all other cash dividends and cash distributions paid on the Common Stock during the 365-day period ending
on the date of declaration of such dividend or distribution (as adjusted to appropriately reflect any of the events referred to
in other subsections of this Section 4 and excluding cash dividends or cash distributions that resulted in an adjustment
to the Warrant Price or to the number of shares of Common Stock issuable on exercise of each Warrant) does not exceed $0.50 (being
5% of the offering price of the Units in the Offering).

 

4.2
Aggregation of Shares. If after the date hereof, and subject to the provisions of Section 4.6 hereof, the number
of outstanding shares of Common Stock is decreased by a consolidation, combination, reverse stock split or reclassification of
shares of Common Stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock split,
reclassification or similar event, the number of shares of Common Stock issuable on exercise of each Warrant shall be decreased
in proportion to such decrease in outstanding shares of Common Stock.

 

4.3
Adjustments in Exercise Price.

 

4.3.1
Whenever the number of shares of Common Stock purchasable upon the exercise of the Warrants is adjusted, as provided in subsection
4.1.1 or Section 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price
immediately prior to such adjustment by a fraction (x) the numerator of which shall be the number of shares of Common Stock purchasable
upon the exercise of the Warrants immediately prior to such adjustment, and (y) the denominator of which shall be the number of
shares of Common Stock so purchasable immediately thereafter.

 

4.3.2
If (i) the Company issues additional shares of Common Stock or securities convertible into or exercisable or exchangeable for
shares of Common Stock for capital raising purposes in connection with the closing of its initial Business Combination at an issue
price or effective issue price of less than $9.20 per share of Common Stock, with such issue price or effective issue price to
be determined in good faith by the Board (and in the case of any such issuance to the Sponsor or its affiliates, without taking
into account any founder shares held by such holder or affiliates, as applicable, prior to such issuance) (the “New
Issuance Price”), (ii) the aggregate gross proceeds from such issuances represent more than 60% of the total equity
proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation
thereof (net of redemptions) and (iii) the volume weighted average trading price of the Common Stock during the 20 trading day
period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price,
the “Market Value”) is below $9.20 per share, the Warrant Price shall be adjusted (to the nearest cent) to be equal
to 115% of the higher of the Market Value and the New Issuance Price and the Redemption Trigger Price (as defined below) shall
be adjusted to equal to 180% of the higher of the Market Value and the Newly Issued Price.

 

    	7

     

    

 

4.4
Replacement of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding
shares of Common Stock (other than a change under subsections 4.1.1 or 4.1.2 or Section 4.2 hereof or that
solely affects the par value of such shares of Common Stock), or in the case of any merger or consolidation of the Company with
or into another entity or conversion of the Company as another entity (other than a consolidation or merger in which the Company
is the continuing corporation and that does not result in any reclassification or reorganization of the outstanding shares of
Common Stock), or in the case of any sale or conveyance to another entity of the assets or other property of the Company as an
entirety or substantially as an entirety in connection with which the Company is dissolved, the holders of the Warrants shall
thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the Warrants
and in lieu of the shares of Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise
of the rights represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable
upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer,
that the holder of the Warrants would have received if such holder had exercised his, her or its Warrant(s) immediately prior
to such event (the “Alternative Issuance” ); provided, however, that in connection with
the closing of any such consolidation, merger, sale or conveyance, the successor or purchasing entity shall execute an amendment
hereto with the Warrant Agent providing for delivery of such Alternative Issuance; provided, further, that (i) if
the holders of the Common Stock were entitled to exercise a right of election as to the kind or amount of securities, cash or
other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets constituting
the Alternative Issuance for which each Warrant shall become exercisable shall be deemed to be the weighted average of the kind
and amount received per share by the holders of the Common Stock in such consolidation or merger that affirmatively make such
election, and (ii) if a tender, exchange or redemption offer shall have been made to and accepted by the holders of the Common
Stock (other than a tender, exchange or redemption offer made by the Company in connection with redemption rights held by stockholders
of the Company as provided for in the Company’s amended and restated certificate of incorporation or as a result of the
repurchase of shares of Common Stock by the Company if a proposed initial Business Combination is presented to the stockholders
of the Company for approval) under circumstances in which, upon completion of such tender or exchange offer, the maker thereof,
together with members of any group (within the meaning of Rule 13d-5(b)(1) under the Exchange Act (or any successor rule)) of
which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under
the Exchange Act (or any successor rule)) and any members of any such group of which any such affiliate or associate is a part,
own beneficially (within the meaning of Rule 13d-3 under the Exchange Act (or any successor rule)) more than 50% of the outstanding
shares of Common Stock, the holder of a Warrant shall be entitled to receive as the Alternative Issuance, the highest amount of
cash, securities or other property to which such holder would actually have been entitled as a stockholder if such Warrant holder
had exercised the Warrant prior to the expiration of such tender or exchange offer, accepted such offer and all of the Common
Stock held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustments (from and after
the consummation of such tender or exchange offer) as nearly equivalent as possible to the adjustments provided for in this Section
4; provided, further, that if less than 70% of the consideration receivable by the holders of the Common Stock
in the applicable event is payable in the form of common stock in the successor entity that is listed for trading on a national
securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately
following such event, and if the Registered Holder properly exercises the Warrant within thirty (30) days following the public
disclosure of the consummation of such applicable event by the Company pursuant to a current report on Form 8-K filed with the
Commission, the Warrant Price shall be reduced by an amount (in dollars) (but in no event less than zero) equal to the difference
of (i) the Warrant Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) minus
(B) the Black-Scholes Warrant Value (as defined below). The “Black-Scholes Warrant Value” means the
value of a Warrant immediately prior to the consummation of the applicable event based on the Black-Scholes Warrant Model for
a Capped American Call on Bloomberg Financial Markets (“Bloomberg”). For purposes of calculating such
amount, (1) Section 6 of this Agreement shall be taken into account, (2) the price of each share of Common Stock shall
be the volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading
day prior to the effective date of the applicable event, (3) the assumed volatility shall be the 90 day volatility obtained from
the HVT function on Bloomberg determined as of the trading day immediately prior to the day of the announcement of the applicable
event, and (4) the assumed risk-free interest rate shall correspond to the U.S. Treasury rate for a period equal to the remaining
term of the Warrant. “Per Share Consideration” means (i) if the consideration paid to
holders of the Common Stock consists exclusively of cash, the amount of such cash per share of Common Stock, and (ii) in all other
cases, the amount of cash per share of Common Stock, if any, plus the volume weighted average price of the Common Stock as reported
during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable event. If any reclassification
or reorganization also results in a change in shares of Common Stock covered by subsection 4.1.1, then such adjustment
shall be made pursuant to subsection 4.1.1 or Sections 4.2, 4.3 and this Section 4.4. The provisions
of this Section 4.4 shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations,
sales or other transfers. In no event will the Warrant Price be reduced to less than the par value per share issuable upon exercise
of the Warrant.

 

    	8

     

    

 

4.5
Notices of Changes in Warrant. Upon every adjustment of the Warrant Price or the number of shares of Common Stock issuable
upon exercise of a Warrant, the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant
Price resulting from such adjustment and the increase or decrease, if any, in the number of shares of Common Stock purchasable
at such price upon the exercise of a Warrant, setting forth in reasonable detail the method of calculation and the facts upon
which such calculation is based. Upon the occurrence of any event specified in Sections 4.1, 4.2, 4.3 or
4.4, the Company shall give written notice of the occurrence of such event to each holder of a Warrant, at the last address
set forth for such holder in the Warrant Register, of the record date or the effective date of the event. Failure to give such
notice, or any defect therein, shall not affect the legality or validity of such event.

 

4.6
No Fractional Shares. Notwithstanding any provision contained in this Agreement to the contrary, the Company shall not
issue fractional shares of Common Stock upon the exercise of Warrants. If, by reason of any adjustment made pursuant to this Section
4, the holder of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share,
the Company shall, upon such exercise, round down to the nearest whole number the number of shares of Common Stock to be issued
to such holder.

 

4.7
Form of Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this Section 4, and
Warrants issued after such adjustment may state the same Warrant Price and the same number of shares of Common Stock as is stated
in the Warrants initially issued pursuant to this Agreement; provided, however, that the Company may at any time
in its sole discretion make any change in the form of Warrant that the Company may deem appropriate and that does not affect the
substance thereof, and any Warrant thereafter issued or countersigned, whether in exchange or substitution for an outstanding
Warrant or otherwise, may be in the form as so changed.

 

4.8
Other Events. In case any event shall occur affecting the Company as to which none of the provisions of preceding subsections
of this Section 4 are strictly applicable, but which would require an adjustment to the terms of the Warrants in order
to (i) avoid an adverse impact on the Warrants and (ii) effectuate the intent and purpose of this Section 4, then, in each
such case, the Company shall appoint a firm of independent public accountants, investment banking or other appraisal firm of recognized
national standing, which shall give its opinion as to whether or not any adjustment to the rights represented by the Warrants
is necessary to effectuate the intent and purpose of this Section 4 and, if they determine that an adjustment is necessary,
the terms of such adjustment, provided, however, that under no circumstances shall the Warrants be adjusted pursuant to this Section
4.8 as a result of any issuance of securities in connection with the Business Combination. The Company shall adjust the terms
of the Warrants in a manner that is consistent with any adjustment recommended in such opinion.

 

5.
Transfer and Exchange of Warrants.

 

5.1
Registration of Transfer. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant
upon the Warrant Register, upon surrender of such Warrant for transfer, in the case of certificated Warrants, properly endorsed
with signatures properly guaranteed and accompanied by appropriate instructions for transfer. Upon any such transfer, a new Warrant
representing an equal aggregate number of Warrants shall be issued and the old Warrant shall be cancelled by the Warrant Agent.
In the case of certificated Warrants, the Warrants so cancelled shall be delivered by the Warrant Agent to the Company from time
to time upon request.

 

5.2
Procedure for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, together with a written request
for exchange or transfer, and thereupon the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested
by the Registered Holder of the Warrants so surrendered, representing an equal aggregate number of Warrants; provided,
however, that except as otherwise provided herein or in any Book-Entry Warrant Certificate or Definitive Warrant Certificate,
each Book-Entry Warrant Certificate and Definitive Warrant Certificate may be transferred only in whole and only to the Depositary,
to another nominee of the Depositary, to a successor depository, or to a nominee of a successor depository; provided further,
however, that in the event that a Warrant surrendered for transfer bears a restrictive legend (as in the case of the Private
Placement Warrants and the Working Capital Warrants), the Warrant Agent shall not cancel such Warrant and issue new Warrants in
exchange thereof until the Warrant Agent has received an opinion of counsel for the Company stating that such transfer may be
made and indicating whether the new Warrants must also bear a restrictive legend.

 

    	9

     

    

 

5.3
Fractional Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange which shall
result in the issuance of a warrant certificate or book-entry position for a fraction of a warrant.

 

5.4
Service Charges. No service charge shall be made for any exchange or registration of transfer of Warrants.

 

5.5
Warrant Execution and Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance
with the terms of this Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and
the Company, whenever required by the Warrant Agent, shall supply the Warrant Agent with Warrants duly executed on behalf of the
Company for such purpose.

 

5.6
Transfer of Warrants. Prior to the Detachment Date, the Public Warrants may be transferred or exchanged only together with
the Unit in which such Warrant is included, and only for the purpose of effecting, or in conjunction with, a transfer or exchange
of such Unit. Furthermore, each transfer of a Unit on the register relating to such Units shall operate also to transfer the Warrants
included in such Unit. Notwithstanding the foregoing, the provisions of this Section 5.6 shall have no effect on any transfer
of Warrants on and after the Detachment Date.

 

6.
Redemption.

 

6.1
Redemption. Subject to Section 6.4 hereof, not less than all of the outstanding Warrants may be redeemed, at the
option of the Company, at any time while they are exercisable and prior to their expiration, at the office of the Warrant Agent,
upon notice to the Registered Holders of the Warrants, as described in Section 6.2 below, at the price of $0.01 per Warrant
(the “Redemption Price”), provided that the last sales price of the Common Stock reported has been at
least $18.00 per share (subject to adjustment in compliance with Section 4 hereof) (the “Redemption Trigger
Price”), on each of twenty (20) trading days within the thirty (30) trading-day period commencing once the Warrants
become exercisable and ending on the third trading day prior to the date on which notice of the redemption is given and provided
that there is an effective registration statement covering the shares of Common Stock issuable upon exercise of the Warrants,
and a current prospectus relating thereto, available throughout the 30-day Redemption Period (as defined in Section 6.2
below) or the Company has elected to require the exercise of the Warrants on a “cashless basis” pursuant to subsection
3.3.1; provided, however, that if and when the Public Warrants become redeemable by the Company, the Company may not exercise
such redemption right if the issuance of shares of Common Stock upon exercise of the Public Warrants is not exempt from registration
or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification.

 

6.2
Date Fixed for, and Notice of, Redemption. In the event that the Company elects to redeem all of the Warrants, the Company
shall fix a date for the redemption (the “Redemption Date”). Notice of redemption shall be mailed by
first class mail, postage prepaid, by the Company not less than thirty (30) days prior to the Redemption Date (the “30-day
Redemption Period”) to the Registered Holders of the Warrants to be redeemed at their last addresses as they shall
appear on the registration books. Any notice mailed in the manner herein provided shall be conclusively presumed to have been
duly given whether or not the Registered Holder received such notice.

 

6.3
Exercise After Notice of Redemption. The Warrants may be exercised, for cash (or on a “cashless basis” in accordance
with subsection 3.3.1(b) of this Agreement) at any time after notice of redemption shall have been given by the Company
pursuant to Section 6.2 hereof and prior to the Redemption Date. In the event that the Company determines to require all
holders of Warrants to exercise their Warrants on a “cashless basis” pursuant to subsection 3.3.1, the notice
of redemption shall contain the information necessary to calculate the number of shares of Common Stock to be received upon exercise
of the Warrants, including the “Fair Market Value” (as such term is defined in subsection 3.3.1(b) hereof)
in such case. On and after the Redemption Date, the record holder of the Warrants shall have no further rights except to receive,
upon surrender of the Warrants, the Redemption Price.

 

    	10

     

    

 

6.4
Exclusion of Private Placement Warrants and Working Capital Warrants. The Company agrees that the redemption rights provided
in this Section 6 shall not apply to the Private Placement Warrants or the Working Capital Warrants if at the time of the
redemption such Private Placement Warrants or the Working Capital Warrants continue to be held by the Sponsor or any Permitted
Transferees, as applicable. However, once such Private Placement Warrants or Working Capital Warrants are transferred (other than
to Permitted Transferees under Section 2.6), the Company may redeem the Private Placement Warrants and the Working Capital
Warrants, provided that the criteria for redemption are met, including the opportunity of the holder of such Private Placement
Warrants or the Working Capital Warrants to exercise the Private Placement Warrants and the Working Capital Warrants prior to
redemption pursuant to Section 6.3. Private Placement Warrants and Working Capital Warrants that are transferred to persons
other than Permitted Transferees shall upon such transfer cease to be Private Placement Warrants or Working Capital Warrants and
shall become Public Warrants under this Agreement.

 

7.
Other Provisions Relating to Rights of Holders of Warrants.

 

7.1
No Rights as Stockholder. A Warrant does not entitle the Registered Holder thereof to any of the rights of a stockholder
of the Company, including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive
rights to vote or to consent or to receive notice as stockholders in respect of the meetings of stockholders or the election of
directors of the Company or any other matter.

 

7.2
Lost, Stolen, Mutilated, or Destroyed Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and
the Warrant Agent may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case
of a mutilated Warrant, include the surrender thereof), issue a new Warrant of like denomination, tenor, and date as the Warrant
so lost, stolen, mutilated, or destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company,
whether or not the allegedly lost, stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone.

 

7.3
Reservation of Common Stock. The Company shall at all times reserve and keep available a number of its authorized but unissued
shares of Common Stock that shall be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to
this Agreement.

 

7.4
Registration of Common Stock; Cashless Exercise at Company’s Option.

 

7.4.1
Registration of the Common Stock. The Company agrees that as soon as practicable, but in no event later than fifteen (15)
Business Days after the closing of its initial Business Combination, it shall use its best efforts to file with the Commission
a registration statement for the registration, under the Securities Act, of the shares of Common Stock issuable upon exercise
of the Warrants. The Company shall use its best efforts to cause the same to become effective and to maintain the effectiveness
of such registration statement, and a current prospectus relating thereto, until the expiration of the Warrants in accordance
with the provisions of this Agreement. If any such registration statement has not been declared effective by the 60th Business
Day following the closing of the Business Combination, holders of the Warrants shall have the right, during the period beginning
on the 61st Business Day after the closing of the Business Combination and ending upon such registration statement being declared
effective by the Commission, and during any other period when the Company shall fail to have maintained an effective registration
statement covering the shares of Common Stock issuable upon exercise of the Warrants, to exercise such Warrants on a “cashless
basis,” by exchanging the Warrants (in accordance with Section 3(a)(9) of the Securities Act (or any successor rule) or
another exemption) for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the
number of shares of Common Stock underlying the Warrants, multiplied by the difference between the Warrant Price and the “Fair
Market Value” (as defined below) by (y) the Fair Market Value; provided, however, that no cashless exercise shall be permitted
unless the Fair Market Value is equal to or higher than the Warrant Price. Solely for purposes of this subsection 7.4.1,
“Fair Market Value” shall mean the volume weighted average price of the Common Stock as reported during the ten (10)
trading day period ending on the trading day prior to the date that notice of exercise is received by the Warrant Agent from the
holder of such Warrants or its securities broker or intermediary. The date that notice of cashless exercise is received by the
Warrant Agent shall be conclusively determined by the Warrant Agent. In connection with the “cashless exercise” of
a Public Warrant, the Company shall, upon request, provide the Warrant Agent with an opinion of counsel for the Company (which
shall be an outside law firm with securities law experience) stating that (i) the exercise of the Warrants on a cashless basis
in accordance with this subsection 7.4.1 is not required to be registered under the Securities Act and (ii) the shares
of Common Stock issued upon such exercise shall be freely tradable under United States federal securities laws by anyone who is
not an affiliate (as such term is defined in Rule 144 under the Securities Act (or any successor statute)) of the Company and,
accordingly, shall not be required to bear a restrictive legend. Except as provided in subsection 7.4.2, for the avoidance
of any doubt, unless and until all of the Warrants have been exercised or have expired, the Company shall continue to be obligated
to comply with its registration obligations under the first three sentences of this subsection 7.4.1.

 

    	11

     

    

 

7.4.2
Cashless Exercise at Company’s Option. If the Common Stock is at the time of any exercise of a Warrant not listed
on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1)
of the Securities Act (or any successor statute), the Company may, at its option, (i) require holders of Public Warrants who exercise
Public Warrants to exercise such Public Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities
Act (or any successor statute) as described in subsection 7.4.1 and (ii) in the event the Company so elects, the Company
shall not be required to file or maintain in effect a registration statement for the registration, under the Securities Act, of
the Common Stock issuable upon exercise of the Warrants, notwithstanding anything in this Agreement to the contrary. If the Company
does not elect at the time of exercise to require a holder of Public Warrants who exercises Public Warrants to exercise such Public
Warrants on a “cashless basis,” it agrees to use its best efforts to register or qualify for sale the Common Stock
issuable upon exercise of the Public Warrant under the blue sky laws of the state of residence of the exercising Public Warrant
holder to the extent an exemption is not available.

 

8.
Concerning the Warrant Agent and Other Matters.

 

8.1
Payment of Taxes. The Company shall from time to time promptly pay all taxes and charges that may be imposed upon the Company
or the Warrant Agent in respect of the issuance or delivery of shares of Common Stock upon the exercise of the Warrants, but the
Company shall not be obligated to pay any transfer taxes in respect of the Warrants or such shares of Common Stock.

 

8.2
Resignation, Consolidation, or Merger of Warrant Agent.

 

8.2.1
Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties
and be discharged from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the
Company. If the office of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall
appoint in writing a successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment
within a period of thirty (30) days after it has been notified in writing of such resignation or incapacity by the Warrant Agent
or by the holder of a Warrant (who shall, with such notice, submit his Warrant for inspection by the Company), then the holder
of any Warrant may apply to the Supreme Court of the State of New York for the County of New York for the appointment of a successor
Warrant Agent at the Company’s cost. Any successor Warrant Agent, whether appointed by the Company or by such court, shall
be a corporation organized and existing under the laws of the State of New York, in good standing and having its principal office
in the Borough of Manhattan, City and State of New York, and authorized under such laws to exercise corporate trust powers and
subject to supervision or examination by federal or state authority. After appointment, any successor Warrant Agent shall be vested
with all the authority, powers, rights, immunities, duties, and obligations of its predecessor Warrant Agent with like effect
as if originally named as Warrant Agent hereunder, without any further act or deed; but if for any reason it becomes necessary
or appropriate, the predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument transferring
to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon request
of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for
more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities,
duties, and obligations.

 

8.2.2
Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice
thereof to the predecessor Warrant Agent and the Transfer Agent for the Common Stock not later than the effective date of any
such appointment.

 

8.2.3
Merger or Consolidation of Warrant Agent. Any corporation into which the Warrant Agent may be merged or with which it may
be consolidated or any corporation resulting from any merger or consolidation to which the Warrant Agent shall be a party shall
be the successor Warrant Agent under this Agreement without any further act.

 

    	12

     

    

 

8.3
Fees and Expenses of Warrant Agent.

 

8.3.1
Remuneration. The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent
hereunder and shall, pursuant to its obligations under this Agreement, reimburse the Warrant Agent upon demand for all expenditures
that the Warrant Agent may reasonably incur in the execution of its duties hereunder.

 

8.3.2
Further Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed,
acknowledged, and delivered all such further and other acts, instruments, and assurances as may reasonably be required by the
Warrant Agent for the carrying out or performing of the provisions of this Agreement.

 

8.4
Liability of Warrant Agent.

 

8.4.1
Reliance on Company Statement. Whenever in the performance of its duties under this Agreement, the Warrant Agent shall
deem it necessary or desirable that any fact or matter be proved or established by the Company prior to taking or suffering any
action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed
to be conclusively proved and established by a statement signed by the Chief Executive Officer, Chief Financial Officer, President,
Executive Vice President, Vice President, Secretary or Chairman of the Board of the Company and delivered to the Warrant Agent.
The Warrant Agent may rely upon such statement for any action taken or suffered in good faith by it pursuant to the provisions
of this Agreement.

 

8.4.2
Indemnity. The Warrant Agent shall be liable hereunder only for its own gross negligence, willful misconduct or bad faith.
The Company agrees to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, costs
and reasonable counsel fees, for anything done or omitted by the Warrant Agent in the execution of this Agreement, except as a
result of the Warrant Agent’s gross negligence, willful misconduct or bad faith.

 

8.4.3
Exclusions. The Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with respect
to the validity or execution of any Warrant (except its countersignature thereof). The Warrant Agent shall not be responsible
for any breach by the Company of any covenant or condition contained in this Agreement or in any Warrant. The Warrant Agent shall
not be responsible to make any adjustments required under the provisions of Section 4 hereof or responsible for the manner,
method, or amount of any such adjustment or the ascertaining of the existence of facts that would require any such adjustment;
nor shall it by any act hereunder be deemed to make any representation or warranty as to the authorization or reservation of any
shares of Common Stock to be issued pursuant to this Agreement or any Warrant or as to whether any shares of Common Stock shall,
when issued, be valid and fully paid and non-assessable.

 

8.5
Acceptance of Agency. The Warrant Agent hereby accepts the agency established by this Agreement and agrees to perform the
same upon the terms and conditions herein set forth and among other things, shall account promptly to the Company with respect
to Warrants exercised and concurrently account for, and pay to the Company, all monies received by the Warrant Agent for the purchase
of shares of Common Stock through the exercise of the Warrants.

 

8.6
Waiver. The Warrant Agent has no right of set-off or any other right, title, interest or claim of any kind (“Claim”)
in, or to any distribution of, the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of
the date hereof, by and between the Company and the Warrant Agent as trustee thereunder) and hereby agrees not to seek recourse,
reimbursement, payment or satisfaction for any Claim against the Trust Account for any reason whatsoever. The Warrant Agent hereby
waives any and all Claims against the Trust Account and any and all rights to seek access to the Trust Account.

 

    	13

     

    

 

9.
Miscellaneous Provisions.

 

9.1
Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent
shall bind and inure to the benefit of their respective successors and assigns.

 

9.2
Notices. Any notice, statement or demand authorized by this Agreement to be given or made by the Warrant Agent or by the
holder of any Warrant to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if
sent by certified mail or private courier service within five (5) days after deposit of such notice, postage prepaid, addressed
(until another address is filed in writing by the Company with the Warrant Agent), as follows:

 

Big
Cypress Acquisition Corp.

300
W. 41st Street, Suite 202

Miami
Beach, FL 33140

Attention:
Samuel J. Reich

 

Any
notice, statement or demand authorized by this Agreement to be given or made by the holder of any Warrant or by the Company to
or on the Warrant Agent shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified
mail or private courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address
is filed in writing by the Warrant Agent with the Company), as follows:

 

Continental
Stock Transfer & Trust Company

1
State Street, 30th Floor

New
York, NY 10004

Attention:
Compliance Department

 

9.3
Applicable Law. The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in
all respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the
application of the substantive laws of another jurisdiction. The Company hereby agrees that any action, proceeding or claim against
it arising out of or relating in any way to this Agreement shall be brought and enforced in the courts of the State of New York
or the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which
jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent
an inconvenient forum. Notwithstanding the foregoing, this Section 9.3 shall not apply to actions brought to enforce any liability
or duty created by the Exchange Act or any other claim for which the federal district courts of the United States of America are
the sole and exclusive forum.

 

9.4
Persons Having Rights under this Agreement. Nothing in this Agreement shall be construed to confer upon, or give to, any
person or corporation other than the parties hereto and the Registered Holders of the Warrants and, for purposes of Sections 7.4,
9.4 and 9.8, the Representative, any right, remedy, or claim under or by reason of this Agreement or of any covenant, condition,
stipulation, promise, or agreement hereof. All covenants, conditions, stipulations, promises, and agreements contained in this
Agreement shall be for the sole and exclusive benefit of the parties hereto and, for purposes of Sections 7.4, 9.4 and 9.8, the
Representative, and their successors and assigns and of the Registered Holders of the Warrants.

 

9.5
Examination of the Warrant Agreement. A copy of this Agreement shall be available at all reasonable times at the office
of the Warrant Agent in the Borough of Manhattan, City and State of New York, for inspection by the Registered Holder of any Warrant.
The Warrant Agent may require any such holder to submit such holder’s Warrant for inspection by the Warrant Agent.

 

9.6
Counterparts. This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts
shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

 

9.7
Effect of Headings. The section headings herein are for convenience only and are not part of this Agreement and shall not
affect the interpretation thereof.

 

    	14

     

    

 

9.8
Amendments. This Agreement may be amended by the parties hereto without the consent of any Registered Holder (i) for the
purpose of curing any ambiguity, or curing, correcting or supplementing any defective provision contained herein or adding or
changing any other provisions with respect to matters or questions arising under this Agreement as the parties may deem necessary
or desirable and that the parties deem shall not adversely affect the interest of the Registered Holders, and (ii) to provide
for the delivery of Alternative Issuance pursuant to Section 4.4. All other modifications or amendments, including any amendment
to increase the Warrant Price or shorten the Exercise Period, shall require the vote or written consent of the Registered Holders
of a majority of the then outstanding Public Warrants. Any amendment solely to the Private Placement Warrants or the Working Capital
Warrants shall require the vote or written consent of a majority of the holders of the then outstanding Private Placement Warrants
or the Working Capital Warrants. Notwithstanding the foregoing, the Company may lower the Warrant Price or extend the duration
of the Exercise Period pursuant to Sections 3.1 and 3.2, respectively, without the consent of the Registered Holders.

 

9.9
Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision
hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore,
in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part
of this Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and
enforceable.

 

[Signature
Page Follows]

 

    	15

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first above written.

 

	 	BIG
    CYPRESS ACQUISITION CORP.
	 	 
	 	By:	/s/
    Samuel J. Reich
	 	Name:	Samuel
    J. Reich 
	 	Title:	Chief
    Executive Officer
	 	 
	 	CONTINENTAL
    STOCK TRANSFER & TRUST COMPANY, as Warrant Agent
	 	 
	 	By:	/s/
    Henry Farrell
	 	Name:	Henry
    Farrell
	 	Title:	Vice
    President

 

[Signature
Page to Warrant Agreement]

 

    	16

     

    

 

EXHIBIT
A

[Form
of Warrant Certificate]

[FACE]

 

Number

 

Warrants

 

THIS
WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO

THE
EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR

IN
THE WARRANT AGREEMENT DESCRIBED BELOW

BIG
CYPRESS ACQUISITION CORP.

 

Incorporated
Under the Laws of the State of Delaware

 

CUSIP
[—]

 

Warrant
Certificate

 

This
Warrant Certificate certifies that , or registered assigns, is the registered holder of warrant(s) evidenced hereby (the
“Warrants” and each, a “Warrant”) to purchase shares of common stock, $0.0001 par value
per share (“Common Stock”), of Big Cypress Acquisition Corp., a Delaware corporation (the “Company”).
Each whole Warrant entitles the holder, upon exercise during the period set forth in the Warrant Agreement referred to below,
to receive from the Company that number of fully paid and non-assessable shares of Common Stock as set forth below, at the exercise
price (the “Exercise Price”) as determined pursuant to the Warrant Agreement, payable in lawful money
(or through “cashless exercise” as provided for in the Warrant Agreement) of the United States of America
upon surrender of this Warrant Certificate and payment of the Exercise Price at the office or agency of the Warrant Agent referred
to below, subject to the conditions set forth herein and in the Warrant Agreement. Defined terms used in this Warrant Certificate
but not defined herein shall have the meanings given to them in the Warrant Agreement.

 

Each
whole Warrant is initially exercisable for one fully paid and non-assessable share of Common Stock. No fractional shares will
be issued upon exercise of any Warrant. If, upon the exercise of Warrants, a holder would be entitled to receive a fractional
interest in a share of Common Stock, the Company will, upon exercise, round down to the nearest whole number the number of shares
of Common Stock to be issued to the Warrant holder. The number of shares of Common Stock issuable upon exercise of the Warrants
is subject to adjustment upon the occurrence of certain events set forth in the Warrant Agreement.

 

The
initial Exercise Price per share of Common Stock for any Warrant is equal to $11.50 per whole share. The Exercise Price is subject
to adjustment upon the occurrence of certain events set forth in the Warrant Agreement.

 

Subject
to the conditions set forth in the Warrant Agreement, the Warrants may be exercised only during the Exercise Period and to the
extent not exercised by the end of such Exercise Period, such Warrants shall become void.

 

Reference
is hereby made to the further provisions of this Warrant Certificate set forth on the reverse hereof and such further provisions
shall for all purposes have the same effect as though fully set forth at this place.

 

This
Warrant Certificate shall not be valid unless countersigned by the Warrant Agent, as such term is used in the Warrant Agreement.

 

    	A-1

     

    

 

This
Warrant Certificate shall be governed by and construed in accordance with the internal laws of the State of New York, without
regard to conflicts of laws principles thereof.

 

	 	BIG
    CYPRESS ACQUISITION CORP.
	 	 	 
	 	By:	                  
	 	Name:
    	 
	 	Title:	 
	 	 	 
	 	CONTINENTAL
    STOCK TRANSFER & TRUST COMPANY, as Warrant Agent
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 

 

[Signature
Page to Warrant Certificate]

 

    	A-2

     

    

 

[Form
of Warrant Certificate]

[Reverse]

 

The
Warrants evidenced by this Warrant Certificate are part of a duly authorized issue of Warrants entitling the holder on exercise
to receive shares of Common Stock and are issued or to be issued pursuant to a Warrant Agreement dated as of , 2021 (the “Warrant
Agreement”), duly executed and delivered by the Company to Continental Stock Transfer & Trust Company, a New
York corporation, as warrant agent (the “Warrant Agent”), which Warrant Agreement is hereby incorporated
by reference in and made a part of this instrument and is hereby referred to for a description of the rights, limitation of rights,
obligations, duties and immunities thereunder of the Warrant Agent, the Company and the holders (the words “holders”
or “holder” meaning the Registered Holders or Registered Holder, respectively) of the Warrants. A copy
of the Warrant Agreement may be obtained by the holder hereof upon written request to the Company. Defined terms used in this
Warrant Certificate but not defined herein shall have the meanings given to them in the Warrant Agreement.

 

Warrants
may be exercised at any time during the Exercise Period set forth in the Warrant Agreement. The holder of Warrants evidenced by
this Warrant Certificate may exercise them by surrendering this Warrant Certificate, with the form of election to purchase set
forth hereon properly completed and executed, together with payment of the Exercise Price as specified in the Warrant Agreement
(or through “cashless exercise” as provided for in the Warrant Agreement) at the principal corporate trust office
of the Warrant Agent. In the event that upon any exercise of Warrants evidenced hereby the number of Warrants exercised shall
be less than the total number of Warrants evidenced hereby, there shall be issued to the holder hereof or his, her or its assignee,
a new Warrant Certificate evidencing the number of Warrants not exercised.

 

Notwithstanding
anything else in this Warrant Certificate or the Warrant Agreement, no Warrant may be exercised unless at the time of exercise
(i) a registration statement covering the shares of Common Stock to be issued upon exercise is effective under the Securities
Act and (ii) a prospectus thereunder relating to the shares of Common Stock is current, except through “cashless exercise”
as provided for in the Warrant Agreement.

 

The
Warrant Agreement provides that upon the occurrence of certain events the number of shares of Common Stock issuable upon exercise
of the Warrants set forth on the face hereof may, subject to certain conditions, be adjusted. If, upon exercise of a Warrant,
the holder thereof would be entitled to receive a fractional interest in a share of Common Stock, the Company shall, upon exercise,
round down to the nearest whole number of shares of Common Stock to be issued to the holder of the Warrant.

 

Warrant
Certificates, when surrendered at the principal corporate trust office of the Warrant Agent by the Registered Holder thereof in
person or by legal representative or attorney duly authorized in writing, may be exchanged, in the manner and subject to the limitations
provided in the Warrant Agreement, but without payment of any service charge, for another Warrant Certificate or Warrant Certificates
of like tenor evidencing in the aggregate a like number of Warrants.

 

Upon
due presentation for registration of transfer of this Warrant Certificate at the office of the Warrant Agent a new Warrant Certificate
or Warrant Certificates of like tenor and evidencing in the aggregate a like number of Warrants shall be issued to the transferee(s)
in exchange for this Warrant Certificate, subject to the limitations provided in the Warrant Agreement, without charge except
for any tax or other governmental charge imposed in connection therewith.

 

The
Company and the Warrant Agent may deem and treat the Registered Holder(s) hereof as the absolute owner(s) of this Warrant Certificate
(notwithstanding any notation of ownership or other writing hereon made by anyone), for the purpose of any exercise hereof, of
any distribution to the holder(s) hereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected
by any notice to the contrary. Neither the Warrants nor this Warrant Certificate entitles any holder hereof to any rights of a
stockholder of the Company.

 

    	A-3

     

    

 

Election
to Purchase

(To
Be Executed Upon Exercise of Warrant)

 

The
undersigned hereby irrevocably elects to exercise the right, represented by this Warrant Certificate, to receive shares of Common
Stock and herewith tenders payment for such shares of Common Stock to the order of Big Cypress Acquisition Corp. (the “Company”)
in the amount of $ in accordance with the terms hereof. The undersigned requests that a certificate for such shares of Common
Stock be registered in the name of , whose address is and that such shares of Common Stock be delivered to whose address is .
If said number of shares of Common Stock is less than all of the shares of Common Stock purchasable hereunder, the undersigned
requests that a new Warrant Certificate representing the remaining balance of such shares of Common Stock be registered in the
name of , whose address is and that such Warrant Certificate be delivered to , whose address is .

 

In
the event that the Warrant has been called for redemption by the Company pursuant to Section 6 of the Warrant Agreement
and the Company has required cashless exercise pursuant to Section 6.3 of the Warrant Agreement, the number of shares of
Common Stock that this Warrant is exercisable for shall be determined in accordance with subsection 3.3.1(b) and Section
6.3 of the Warrant Agreement.

 

In
the event that the Warrant is a Private Placement Warrant, Working Capital Warrant or Post-IPO Warrant that is to be exercised
on a “cashless” basis pursuant to subsection 3.3.1(c) of the Warrant Agreement, the number of shares of Common
Stock that this Warrant is exercisable for shall be determined in accordance with subsection 3.3.1(c) of the Warrant Agreement.

 

In
the event that the Warrant is to be exercised on a “cashless” basis pursuant to Section 7.4 of the Warrant
Agreement, the number of shares of Common Stock that this Warrant is exercisable for shall be determined in accordance with Section
7.4 of the Warrant Agreement.

 

In
the event that the Warrant may be exercised, to the extent allowed by the Warrant Agreement, through cashless exercise (i) the
number of shares of Common Stock that this Warrant is exercisable for would be determined in accordance with the relevant section
of the Warrant Agreement which allows for such cashless exercise and (ii) the holder hereof shall complete the following: The
undersigned hereby irrevocably elects to exercise the right, represented by this Warrant Certificate, through the cashless exercise
provisions of the Warrant Agreement, to receive shares of Common Stock. If said number of shares of Common Stock is less than
all of the shares of Common Stock purchasable hereunder (after giving effect to the cashless exercise), the undersigned requests
that a new Warrant Certificate representing the remaining balance of such shares of Common Stock be registered in the name of
, whose address is and that such Warrant Certificate be delivered to , whose address is .

 

[Signature
Page Follows]

 

    	A-4

     

    

 

	Date:
    , 20	 
	 	(Signature)
	 	 
	 	 
	 	 
	 	 
	 	(Address)
	 	 
	 	 
	 	(Tax
    Identification Number)
	 	 
	Signature
    Guaranteed:	 
	 	 
	 	 

 

THE
SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND
CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15 (OR ANY SUCCESSOR
RULE)).

 

    	A-5

     

    

 

EXHIBIT
B

LEGEND

 

“THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE
SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT
OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS OR AN EXEMPTION FROM REGISTRATION IS AVAILABLE. IN ADDITION, SUBJECT
TO ANY ADDITIONAL LIMITATIONS ON TRANSFER DESCRIBED IN THE LETTER AGREEMENT BY AND AMONG BIG CYPRESS ACQUISITION CORP. (THE “COMPANY”),
BIG CYPRESS HOLDINGS LLC AND THE OTHER PARTIES THERETO, THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD OR TRANSFERRED
PRIOR TO THE DATE THAT IS THIRTY (30) DAYS AFTER THE DATE UPON WHICH THE COMPANY COMPLETES ITS INITIAL BUSINESS COMBINATION (AS
DEFINED IN SECTION 3 OF THE WARRANT AGREEMENT REFERRED TO HEREIN) EXCEPT TO A PERMITTED TRANSFEREE (AS DEFINED IN SECTION 2 OF
THE WARRANT AGREEMENT) WHO AGREES IN WRITING WITH THE COMPANY TO BE SUBJECT TO SUCH TRANSFER PROVISIONS.

 

SECURITIES
EVIDENCED BY THIS CERTIFICATE AND SHARES OF COMMON STOCK OF THE COMPANY ISSUED UPON EXERCISE OF SUCH SECURITIES SHALL BE ENTITLED
TO REGISTRATION RIGHTS UNDER A REGISTRATION RIGHTS AGREEMENT TO BE EXECUTED BY THE COMPANY.”

 

    	B-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}]]